US20020019593A1 - System and method for classifying cardiac complexes - Google Patents

System and method for classifying cardiac complexes Download PDF

Info

Publication number
US20020019593A1
US20020019593A1 US09/848,605 US84860501A US2002019593A1 US 20020019593 A1 US20020019593 A1 US 20020019593A1 US 84860501 A US84860501 A US 84860501A US 2002019593 A1 US2002019593 A1 US 2002019593A1
Authority
US
United States
Prior art keywords
cardiac
complex
signal
morphology
nsr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US09/848,605
Other versions
US6438410B2 (en
Inventor
William Hsu
Joseph Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cardiac Pacemakers Inc
Original Assignee
Cardiac Pacemakers Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US09/249,128 priority Critical patent/US6266554B1/en
Application filed by Cardiac Pacemakers Inc filed Critical Cardiac Pacemakers Inc
Priority to US09/848,605 priority patent/US6438410B2/en
Publication of US20020019593A1 publication Critical patent/US20020019593A1/en
Application granted granted Critical
Publication of US6438410B2 publication Critical patent/US6438410B2/en
Anticipated expiration legal-status Critical
Application status is Expired - Fee Related legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/04Measuring bioelectric signals of the body or parts thereof
    • A61B5/0402Electrocardiography, i.e. ECG
    • A61B5/0452Detecting specific parameters of the electrocardiograph cycle
    • A61B5/04525Detecting specific parameters of the electrocardiograph cycle by template matching
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235Details of waveform analysis
    • A61B5/7264Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362Heart stimulators
    • A61N1/3621Heart stimulators for treating or preventing abnormally high heart rate
    • A61N1/3622Heart stimulators for treating or preventing abnormally high heart rate comprising two or more electrodes co-operating with different heart regions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362Heart stimulators
    • A61N1/37Monitoring; Protecting
    • A61N1/3702Physiological parameters
    • A61N1/3704Circuits specially adapted therefor, e.g. for sensitivity control

Abstract

The present invention provides a system and a method for classifying cardiac complexes based on cardiac information derived from two or more cardiac signals. Two or more cardiac signals containing cardiac complexes are monitored. A cardiac complex in the two or more cardiac signals is isolated in an analysis window. The morphology of the cardiac complex in each of the two or more cardiac signals is then compared to the morphology of a template cardiac complex representing a predetermined cardiac condition. Based on this comparison, the cardiac complex is classified as either belonging or not belonging to the predetermined cardiac condition.

Description

    FIELD OF THE INVENTION
  • This invention relates generally to the field of medical devices and more particularly to a system and method for classifying sensed cardiac complexes. [0001]
  • BACKGROUND
  • Effective, efficient ventricular pumping action depends on proper cardiac function. Proper cardiac function, in turn, relies on the synchronized contractions of the heart at regular intervals. When normal cardiac rhythm is initiated at the sinoatrial node, the heart is said to be in sinus rhythm. However, when the heart experiences irregularities in its coordinated contraction, due to electrophysiological disturbances caused by a disease process or from an electrical disturbance, the heart is denoted to be arrhythmic. The resulting cardiac arrhythmia impairs cardiac efficiency and can be a potential life threatening event. [0002]
  • Cardiac arrhythmias occurring in the atrial of the heart are called supraventricular tachyarrhythmias (SVTs). Cardiac arrhythmias occurring in the ventricular region of the heart are called ventricular tachyarrhythmias (VTs). SVTs and VTs are morphologically and physiologically distinct events. VTs take many forms, including ventricular fibrillation and ventricular tachycardia. Ventricular fibrillation is a condition denoted by extremely rapid, nonsynchronous contractions of the ventricles. This condition is fatal unless the heart is returned to sinus rhythm within a few minutes. Ventricular tachycardia are conditions denoted by a rapid heart beat, 150 to 250 beats per minute, that has its origin in some abnormal location within the ventricular myocardium. The abnormal location is typically results from damage to the ventricular myocardium from a myocardial infarction. Ventricular tachycardia can quickly degenerate into ventricular fibrillation. [0003]
  • SVTs also take many forms, including atrial fibrillation and atrial flutter. Both conditions are characterized by rapid uncoordinated contractions of the atria. Besides being hemodynamically inefficient, the rapid contractions of the atria can also adversely effect the ventricular rate. This occurs when the aberrant contractile impulse in the atria are transmitted to the ventricles. It is then possible for the aberrant atrial signals to induce VTs, such as a ventricular tachycardia. [0004]
  • Implantable cardioverter/defibrillators (ICDs) have been established as an effective treatment for patients with serious ventricular tachyarrhythmias. ICDs are able to recognize and treat tachyarrhythmias with a variety of tiered therapies. These tiered therapies range from providing antitachycardia pacing or cardioversion energy for treating tachycardia to defibrillation energy for treating ventricular fibrillation. To effectively deliver these treatments, the ICD must first identify the what type of tachyrhythmia is occurring in the heart. [0005]
  • Attempts at identifying tachyarrhythmias have included comparing the morphologies of individual cardiac complexes to model or template cardiac complexes. Template cardiac complex morphologies are created from cardiac complexes sensed from a signal channel electrogram. Once created, the template cardiac complex morphologies are integrated into morphology algorithms programmed into the ICD. As the ICD encounters a tachycardia episode, cardiac complexes sensed on the single channel electrogram are compared to the template cardiac complex morphologies in the morphology algorithms. Comparing the morphologies of each cardiac complex to the template cardiac complex requires the signals of the two complexes to be positioned over each other. The morphologies of the signals are then analyzed in a time and energy intensive signal shape analysis to determine whether the cardiac complex should be classified as a template cardiac complex. [0006]
  • For the reasons stated above, and for other reasons stated below which will become apparent to those skilled in the art upon reading and understanding the present specification, there is a need in the art for providing a reliable system and method for analyzing and classifying cardiac complexes in a more time and energy efficient manner. [0007]
  • SUMMARY OF THE INVENTION
  • As explained in detail below, the present subject matter utilizes cardiac information from two or more cardiac signals to analyze and classify sensed cardiac complexes in a more time and energy efficient manner. The two or more cardiac signals are sensed from two or more locations within, or on, the heart of the patient. A cardiac complex sensed using two or more cardiac signals includes the relative time at which the cardiac complex is sensed in each of the two or more cardiac signals. This additional factor allows for a more efficient comparison to be made between a sensed cardiac complex and a template cardiac complex representing a predetermined cardiac condition. Based on the comparison, the cardiac complex is classified and this information is used to either determine what type of therapy to deliver to a patient or to assess the occurrence of a variety of predetermined cardiac conditions which may be helpful in providing treatment to the patient. [0008]
  • In one embodiment, the present subject matter provides for the monitoring of two or more cardiac signals representative of a patient's cardiac activity. A cardiac complex is detected in each of the two or more cardiac signals, where the cardiac complex in each of the two or more cardiac signals represents at least a portion of the heart's cardiac cycle. The morphology of the cardiac complex in each of the two or more cardiac signals is then compared to the morphology of a template cardiac complex. Based on the morphology comparison, the cardiac complex is then classified as either being associated with the template cardiac complex or not being associated with the template cardiac complex. [0009]
  • In one embodiment, a first signal and a second signal representative of electrical cardiac activity are monitored. As the first signal is being monitored it is analyzed to detect the onset of a tachycardia episode. When a tachycardia episode is detected, individual cardiac complexes in the first signal and the second signal are detected and windowed for analysis. Predetermined features are then located in the cardiac complex detected in the first signal and in a first normal sinus rhythm representative complex. In one embodiment, the predetermined features include repeatably identifiable complex sections common to the cardiac complex detected in the first signal and the first NSR representative complex. [0010]
  • The predetermined features located in the first signal and in the first NSR representative complex are then aligned within the analysis window. The cardiac complex detected in the second signal is then compared to a second NSR representative complex to determine whether the cardia complex is an arrhythmic cardiac complex. In one embodiment, the morphology of the second NSR representative complex and the morphology of the cardiac complex detected in the second signal to determine whether the cardia complex is an arrhythmic complex. [0011]
  • In an alternative embodiment, as a cardiac complexes are detected in the first signal and the second signal they are windowed for analysis. Predetermined features are then located in the cardiac complex detected in the first signal and in a first normal sinus rhythm representative complex. Scalar values are then generated as a function of the position, or location, of the predetermined features in each of the cardiac signals. The scalar values are then used to create a cardiac vector which represents the cardiac complex. [0012]
  • The cardiac vector is compared to one or more classification vectors, where each of the one or more classification vectors represents a predetermined cardiac condition. A similarity coefficient is determined for the comparison between the cardiac vector and each of the one or more classification vectors. When a similarity coefficient for the comparison of the cardiac vector and a classification vector exceeds a predetermined threshold, the cardiac complex is classified as the predetermined cardiac condition represented by the classification vector. [0013]
  • Additionally, the cardiac vector can be aligned with a classification vector prior to comparing the two vectors. In one embodiment, the process of aligning includes adjusting each scalar value in the cardiac vector so one of the element positions of the cardiac vector equals a scalar value in a corresponding element position in a classification vector. [0014]
  • In an alternative embodiment, as a cardiac complexes are detected in the first signal and the second signal they are windowed for analysis. The morphology of the cardiac complex in the first cardiac signal and the second cardiac signal is then compared to a first template morphology and a second template morphology, respectively. The cardiac complex is then classified based on the comparison of the morphology of the cardiac complex in the first cardiac signal and the second cardiac signal to the first template morphology and the second template morphology. [0015]
  • These and other features and advantages of the invention will become apparent from the following description of the embodiments of the invention.[0016]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is an embodiment of a cardiac complex sensed in two or more cardiac signals according to the present subject matter; [0017]
  • FIG. 2 is an embodiment of cardiac vectors plotted on a three-dimensional Cartesian coordinate system; [0018]
  • FIG. 3 is a flow diagram illustrating one embodiment of the present subject matter; [0019]
  • FIG. 4 is an embodiment of a cardiac complex sensed in two or more cardiac signals according to the present subject matter; [0020]
  • FIG. 5 is a schematic view of one embodiment of an implantable medical device with an endocardial lead implanted in a heart from which segments have been removed to show details; [0021]
  • FIG. 6 is a block diagram of an implantable medical device according to one embodiment of the present subject matter; [0022]
  • FIG. 7 is a flow diagram illustrating one embodiment of the present subject matter; [0023]
  • FIG. 8 is one embodiment of aligning cardiac complexes according to the present subject matter; [0024]
  • FIG. 9 is one embodiment of aligning cardiac complexes according to the present subject matter; [0025]
  • FIG. 10 is a flow diagram illustrating one embodiment of the present subject matter; [0026]
  • FIG. 11 is a flow diagram illustrating one embodiment of the present subject matter; and [0027]
  • FIG. 12 is a flow diagram illustrating one embodiment of the present subject matter.[0028]
  • DETAILED DESCRIPTION
  • In the following detailed description, reference is made to the accompanying drawings which form a part hereof and in which is shown by way of illustration specific embodiments in which the invention may be practiced. These embodiments are described in sufficient detail to enable those skilled in the art to practice and use the invention, and it is to be understood that other embodiments may be utilized and that electrical, logical, and structural changes may be made without departing from the spirit and scope of the present invention. The following detailed description is, therefore, not to be taken in a limiting sense and the scope of the present invention is defined by the appended claims and their equivalents. [0029]
  • The embodiments of the present subject matter illustrated herein are described as being included in an implantable cardiac defibrillator, which may include numerous pacing modes known in the art and an external medical device programmer. In one embodiment, the implantable cardiac defibrillator is a single chamber defibrillator. In an alternative embodiment, the implantable cardiac defibrillator is a dual chamber defibrillator. Examples of both single and dual chamber implantable cardiac defibrillators are known in the art. However, the present medical system can also be implemented in an external cardioverter/monitor system as are known in the art. Also, the present medical system can also be implemented in an implantable atrial cardioverter-defibrillator, which may include numerous pacing modes known in the art. Furthermore, although the present system is described in conjunction with an implantable cardiac defibrillator having a microprocessor based architecture, it will be understood that the implantable cardiac defibrillator (or other implanted device) may be implemented in any logic based custom integrated circuit architecture, if desired. [0030]
  • With respect to the present subject matter, accurate classification of sensed cardiac complexes is important to an overall diagnosis and treatment of a patient's cardiac condition. In an effort to classify and catagorize sensed cardiac complexes, the morphology of individual cardiac complexes is compared to template cardiac complexes. The template cardiac complexes are derived from cardiac complexes sensed during arrhythmic or non-arrhythmic cardiac episodes. [0031]
  • The cardiac signals used in creating the template cardiac complex and classifying sensed cardiac complexes have typically been detected using a signal channel electrogram. Single channel electrograms, however, limit the amount of cardiac information available to use in classifying cardiac complexes. In contrast, one unique aspect of the present subject matter is that cardiac information from two or more cardiac channels is used to classify sensed cardiac complexes. Using two or more cardiac channels provides cardiac information from two or more locations within, or on, the heart of the patient. By utilizing multiple cardiac channels, cardiac information (e.g., sensed cardiac complexes) from the two or more cardiac regions and/or locations provide a larger overall and more complete “view” of the sensed cardiac complexes. [0032]
  • The present subject matter uses two or more electrogram channels in a process of analyzing and classifying cardiac complexes. Each electrogram channel is used to sense a cardiac signal, where the cardiac signal includes cardiac complexes representative of at least a portion of a cardiac cycle. By way of example, and not by way of limitation, portions of the cardiac cycle sensed can include, but are not limited to, P-waves, QRS-cardiac complexes, and R-waves. Other portions of the cardiac cycle, including sensed signals of the entire cardiac complex are considered useful and with the scope of the present subject matter. [0033]
  • In one embodiment, the present subject matter provides for two or more electrogram channels to simultaneously record cardiac complexes as they occur in the heart. As the cardiac complexes occur, each electrogram channel detects cardiac complexes representing portions of the cardiac cycle. The two or more electrogram channels are being sensed from sensors in or on different cardiac locations. While sensors may detect the electrical activity during the same portion of the cardiac cycle, having the sensors in different cardiac locations allows for cardiac information about the same cardiac complex to be gathered from a different “view” of the cardiac cycle. Each cardiac complex sensed with the two or more electrogram channels is placed in an analysis window, where the cardiac complex is isolated for analysis. In one embodiment, each cardiac complex is windowed by isolating and plotting the portions of the simultaneously sensed cardiac complex in the two or more electrogram channels as they occurred in time. [0034]
  • FIG. 1 shows one embodiment of a windowed cardiac complex [0035] 100. In the present example, the windowed cardiac complex 100 has a first cardiac channel 104, a second cardiac channel 108 and a third cardiac channel 112. Cardiac complexes are sensed over the first cardiac channel 104, the second cardiac channel 108 and the third cardiac channel 112, where each cardiac channel may sense a different portion of the cardiac complex (e.g,, R-wave, QRS-cardiac complex, P-wave, etc.). In the present example, the windowed cardiac complex 100 has three views of a cardiac complex as sensed over the three cardiac channels. A first cardiac complex 116 is shown in cardiac signal sensed in the first cardiac channel 104. A second cardiac complex 120 is shown in cardiac signal sensed in the second cardiac channel 108. Finally, a third cardiac complex 123 is shown in cardiac signal sensed in the third cardiac channel 112. The first, second and third cardiac complex 116, 120 and 124 are representative of at least a portion of a single cardiac cycle. In one embodiment, the first, second and third cardiac complex 116, 120 and 124 are snapshots of the single cardiac cycle taken either at different locations within or on the heart and/or taken using different electrode configurations (e.g., far-field, near-field).
  • Cardiac information is derived from the windowed cardiac complexes. In one embodiment, information derived from the windowed cardiac complexes includes values derived or taken from one or more predetermined features on the cardiac complex sensed in each of the two or more cardiac channels. By way of example, and not by limitation, predetermined features of the cardiac complexes that are useful in deriving information include a maximum deflection of the cardiac complex, a beginning of a cardiac complex as indicated by a predetermined deviation of the cardiac signal from a baseline signal, an ending of a cardiac complex as indicated by a return of the first cardiac signal to a baseline signal and a fiducial point (the point of greatest slope along the cardiac complex signal). Other features of the cardiac complex signal are also useful for deriving information. In one embodiment, the selection criteria for these additional features of a cardiac complex is that the feature be a repeatably identifiable portion of the cardiac complex. In one embodiment, the features are selectively programmed into the medical device system. [0036]
  • FIG. 1 shows several examples of predetermined features of the sensed cardiac complex that are useful in deriving information. In one embodiment, a beginning of the first, second and third cardiac complex ([0037] 116, 120 and 124) sensed in the first, second and third cardiac channel (104, 108 and 112), respectively, is generally shown at 128. A maximum deflection point of the first, second and third cardiac complex (116, 120 and 124) is shown generally at 132. Finally, an ending point of the first, second and third cardiac complex (116, 120 and 124) is shown generally at 136.
  • In one embodiment, the cardiac complexes sensed in the two or more cardiac channels are windowed with each of the signals of the cardiac complexes represented as a voltage at a function of time. FIG. 1 shows an example of the first, second and third cardiac complex ([0038] 116, 120 and 124) sensed in the first, second and third cardiac channel (104, 108 and 112) being plotted as voltage as a function of time. Once the cardiac complex sensed in the two or more cardiac channels is represented in this fashion, information can be derived from the specific features of the cardiac complexes.
  • In one embodiment, the information derived from the cardiac complexes in each of the cardiac channels is the time the repeatably identifiable feature of the cardiac complex occurred. Alternatively, the information derived is a time difference between pairs of repeatably identifiable features on a cardiac complex sensed in one of the two or more electrogram channels. In one embodiment, a first time difference [0039] 140 is between the beginning 128 of the first cardiac complex 116 and the end 136 of the first cardiac complex. In an additional embodiment, the information derived is a time difference between pairs of repeatably identifiable features on two different cardiac complexes sensed in two electrogram channels. In a further embodiment, the information derived is a combination of the time difference between pairs of repeatably identifiable features on two different cardiac complexes sensed in two electrogram channels and the time differences from pairs of repeatably identifiable features on a cardiac complex sensed in one of the two or more electrogram channels.
  • Information from multiple cardiac channels can then be used to represent the cardiac complex. In one embodiment, the cardiac complex sensed in multiple cardiac channels can be numerically represented. One way of numerically representing the cardiac complex is to use scalar values derived from the cardiac signals of the cardiac complex. In one embodiment, the scalar values derived from the cardiac signals of the cardiac complex are the times repeatably identifiable features of the cardiac complex occur. Alternatively, time differences between the repeatably identifiable features, as previously described, are used to derive the scalar values. In an additional embodiment, the scalar values can be derived from a magnitude of the position of the predetermined feature for each of the two or more cardiac signals. In one embodiment, the magnitude of the position of the predetermined feature is the voltage measurement of the maximum deflection position along the cardiac signal. [0040]
  • The values derived for a cardiac complex are then used to create an “N” dimensional cardiac complex vector. In one embodiment, the cardiac complex vector has the form: A=[A[0041] 1, A2, A3 . . . An], where each of the values A1-An represent scalar values derived from the repeatably identifiable features of the cardiac complex. The cardiac complex vector represents the cardiac complex, and is used to identify and classify the cardiac complex.
  • Once the cardiac complex vector has been derived from cardiac complex information taken from the two or more cardiac channels, the cardiac complex vector is compared to one or more classification vectors. In one embodiment, a classification vector represent a typical cardiac complex of a specific cardiac arrhythmia or cardiac state. For example, a classification vector can represent a ventricular tachycardia (VT) complex, where there can be one or more classification vectors to represent one or more different manifestations of ventricular tachycardia complexes. Additionally, classification vectors can represent supraventricular tachycardia (SVT) complexes, premature ventricular contraction (PVC) complexes, complexes indicating ischemic events, and any predefined representation of a cardiac complex. [0042]
  • In one embodiment, classification vectors are predefined classification vectors derived from cardiac complexes sensed over two or more cardiac channels for a population of patients. In one embodiment, the population of patients chosen to determine a classification vector display or manifest the cardiac condition of interest (e.g., VT, SVT, PVC). Cardiac complexes of the cardiac conditions of interest are recorded over two or more cardiac channels from the patients. Using repeatably identifiable features of the multiple cardiac signals representing each cardiac complex, classification vectors for a cardiac condition are developed. In one embodiment, cardiac complexes are sensed and recorded during Holter monitoring. [0043]
  • In one embodiment, the classification vectors has the form: C=[C[0044] 1, C2, C3, . . . Cn], where each of the values C1-Cn represent scalar values derived from the repeatably identifiable features of the cardiac complexes. In one embodiment, each of the values C1-Cn are average values derived from repeatably identifiable features of the cardiac complexes for the patient population. In an alternative embodiment, each of the values C1-Cn are median values derived from repeatably identifiable features of the cardiac complexes for the patient population. One or more of the predetermined classification vectors can then be used in the implantable medical device to classify sensed cardiac complexes.
  • In an alternative embodiment, the classification vectors are derived from cardiac complexes sensed from the patient. In one embodiment, two or more cardiac signals are recorded from the patient for a predetermined length of time. In one embodiment, sensing and recording the cardiac complexes is accomplished through Holter monitoring. From the recorded cardiac complexes, classification vectors are developed as previously discussed. In an additional embodiment, classification vectors represent predefined deviations between two or more repeatably identifiable features of a cardiac complex in the two or more cardiac signals. In this embodiment, the classification vector is not representing a particular cardiac condition (e.g., VT, SVT, PVC complex) but rather is representative of a very specific cardiac condition or occurrence that the physician want to pay particular attention to. By developing and programming this type of classification vector, the physician can determine how may cardiac complexes of this particular type are occurring. [0045]
  • In an alternative embodiment, classification vectors are created after the medical device system has been implanted into the patient. One way to create patient specific classification vectors is to derive scalar values from predetermined features of the cardiac complexes sensed in the two or more cardiac channels. As the scalar values are determined from the first sensed cardiac complex, the medical device system determines the cardiac complex vector. The cardiac complex vector for the first cardiac complex is then classified as a first class of sensed cardiac complexes. As the second cardiac complex is sensed, the medical device system determines the cardiac complex vector A for the second cardiac complex. The cardiac complex vector A for the second cardiac complex is then compared to the cardiac complex vector A for the first cardiac complex to determine whether the second cardiac complex should be classified in the first class of sensed cardiac complexes or classified in a second class of sensed cardiac complexes. [0046]
  • In one embodiment, determining whether a cardiac complex should be grouped with one or more classified cardiac complexes is accomplished through a process of comparing the complex vector A of the cardiac complex to be classified with the complex vector A of the cardiac complex that founded the class of cardiac complexes. FIG. 2 shows an embodiment of cardiac complex classes. FIG. 2 shows cardiac complexes being plotted in a Cartesian coordinate system with three-dimensions [0047] 200. Cardiac vectors plotted in 200 have three values A=[A1, A2, A3]. As the first cardiac complex of a patient is sensed, the cardiac vector is determined. As previously discussed, the first cardiac complex becomes the first class of sensed cardiac complexes. The cardiac vector of the first cardiac complex is shown at 204.
  • The cardiac vector of the first cardiac complex not only establishes the first class of sensed cardiac complexes, but it is also used to determined whether subsequently sensed cardiac complexes should be included in the first class of sensed cardiac complexes or excluded to join another class of sensed cardiac complex or form a new class of sensed cardiac complexes. In one embodiment, to determine whether a second cardiac complex is classified with the first class of sensed cardiac complexes the cardiac vector of the second cardiac complex is compared to the cardiac vector of the first cardiac complex. [0048]
  • In one embodiment, a mean square error calculation is used to determine if the scalar values of the cardiac vectors are sufficiently close, or within a region, or “neighborhood”, to classify the second cardiac complex in the first class of cardiac complexes. In one embodiment, the mean square error is represented as Σ(Ai[0049] (n class)−Ai)2≦T, where Ai(n class)represents the ith scalar value (A1-An) of the n class (first class, second class, third class, . . ., nth class) of sensed cardiac complexes and T is a predetermined threshold value. In one embodiment, the predetermined threshold value T defines the region around the cardiac complex representing each of the classes of sensed cardiac complexes.
  • FIG. 2 shows one example of a first region [0050] 208 surrounding the cardiac vector of the first cardiac complex 204. As previously discussed, after the second cardiac complex is sensed, the cardiac vector representing the second cardiac complex is compared to the cardiac vector representing the first class of cardiac complexes, which in this case is the first cardiac complex 204. In one embodiment, if the cardiac vector representing the second cardiac complex falls on or within the first region 208, the second cardiac complex is classified as part of the first class of cardiac complexes.
  • In an alternative embodiment, if the cardiac vector representing the second cardiac complex falls outside the first region [0051] 208, the second cardiac complex is used to create a second class of cardiac complexes. In one embodiment, the cardiac vector of the second cardiac complex is shown at 212. A second region 216 surrounds the second cardiac complex 212. As previously discussed, the size of the second region 216 surrounding the second cardiac complex is dependent on the predetermined threshold value T.
  • As a subsequent cardiac complex is sensed a cardiac vector representing the cardiac complex is determined. The cardiac vector is then compared to each established class of cardiac complex. If the cardiac vector is found to fall within the region around a cardiac vector representing a class of cardiac complexes, the cardiac vector is classified with that class of cardiac complexes. So, if the cardiac complex is found to fall into the region representing a third class of cardiac complexes, the cardiac complex would be classified and counted with the third class of cardiac complexes. If, however, the cardiac complex does not fall into a region surrounding one or more classes of cardiac complexes, the cardiac vector of the cardiac complex is used to create a new class (an “nth” cardiac class) of cardiac complexes. [0052]
  • The cardiac vectors that establish a class of cardiac complexes are electronically stored in the implantable medical device. In addition to electronically storing the cardiac vectors, the medical device system also stores at least the electrocardiogram signal of the cardiac complex that established the class of cardiac complexes. In an additional embodiment, values for the cardiac vectors classified in each of the classes of cardiac complexes are also electronically stored in the medical device system. In one embodiment, it is possible that a cardiac complex is classified into two or more classes of cardiac complexes. In one embodiment, the cardiac complex falling into two or more classes of cardiac complexes will be reported in each class of cardiac complexes. In an alternative embodiment, cardiac complexes falling into two or more classes will classified and reported in the class that they were originally classified. [0053]
  • The patient cardiac complexes are sensed and classified by the implantable medical device for a predetermined period of time. In one embodiment, the predetermined period of time over which cardiac complexes are sensed and used to create the classes of cardiac complexes is programmed by the patient's attending physician. In one embodiment, cardiac complexes are sensed over a continuous period of time. Alternatively, the implantable medical device is programmed to classify sense cardiac complexes during predetermined time segments over the course of 24 hours. Additionally, the implantable medical device is programmed to classify sense cardiac complexes only after the cardiac rate (ventricular and/or atrial rate) has reached or exceeded are predetermined threshold (e.g., known cardiac rate threshold indicative of ventricular tachycardia, atrial tachycardia, etc.). [0054]
  • Upon a follow-up visit to the patient's physician, the cardiac information contained in the implantable medical device is down-loaded to a medical device programmer unit. In one embodiment, information relating to cardiac complexes used to establish classes of cardiac complexes is down-loaded and displayed on a display screen of the medical device programmer. Additionally, the number of cardiac complexes classified into each of the classes of cardiac complexes can be displayed. Electrocardiogram signals representative of each class of cardiac complex can also be displayed. The physician then uses the classes of cardiac complexes to define or designate classification vectors which are subsequently used to identify cardiac complexes and classify a cardiac arrhythmia that the patient may experience. [0055]
  • FIG. 3 shows one embodiment of a method of the present subject matter. At [0056] 300, two or more cardiac signals representative of electrical cardiac activity are monitored. The cardiac signals are monitored to detect cardiac complexes occurring in the two or more cardiac signals. In one embodiment, an implantable medical device, such as an implantable cardioverter defibrillator, is used to detect cardiac complexes in the two or more cardiac signals. In one embodiment, the implantable medical device has two or more cardiac electrodes which allow for near-field and/or far-field cardiac signals to be sensed from a heart.
  • At [0057] 310, the cardiac complex present in the two or more cardiac signals is isolated in an analysis window (or “windowed” for analysis). As previously discussed, windowing isolates a section, or portion, of the two or more cardiac signals which each contain a view of the cardiac complex that is being classified. After the cardiac signals containing the cardiac complex have been isolated, at least one predetermined feature is located in the cardiac complex present in each of the two or more cardiac signals.
  • Once the cardiac signals containing the cardiac complex have been windowed, scalar values from predetermined features of the cardiac complex are generated. In one embodiment, the scalar values are generated as a function of the position of the predetermined feature, or features, on each of the two or more cardiac signals. The scalar values are then used to create a cardiac vector, where the cardiac vector represents the cardiac complex. [0058]
  • FIG. 4 shows one embodiment of cardiac complexes of a cardiac cycle windowed for analysis and classification. A first cardiac complex [0059] 400 is present in the first cardiac signal 404 and a second cardiac complex 408 is present in a second cardiac signal 412. As previously discussed, the two or more cardiac signals are sensed simultaneously from the heart, and so the first cardiac complex 400 and the second cardiac complex 408 are representative of portions of a complete cardiac cycle occurring in the heart.
  • Predetermined features of the cardiac complex in each cardiac signal are used to derive a cardiac vector. In the present example, the cardiac vector is programmed to have four values, such that A=[A[0060] 1, A2, A3, A4]. Each of the values A1-A4 represent scalar values derived from the repeatably identifiable features of the cardiac complex. In one embodiment, A1 is programmed to be the beginning time 416 of the first cardiac complex 400, A2 is programmed to be the time of the maximum deflection point 420 of the first cardiac complex 400, A3 is programmed to be the time difference 424 between the time of the maximum deflection point 420 and the time of the maximum deflection point 428 of the second cardiac complex 408, and A4 is programmed to be the beginning time 432 of the second cardiac complex 408.
  • Referring again to FIG. 3, after a cardiac vector has been determined for the cardiac complex, the cardiac vector is compared to one or more classification vectors at [0061] 330. In one embodiment, the one or more classification vectors represents a predetermined cardiac condition. For example, the predetermined cardiac conditions can include, but are not limited to, ventricular and supraventricular tachycardia, PVCs, ischemia, or other predetermined cardiac conditions designated by a physician. In addition, the cardiac vector has the same vector dimension as the classification vectors. In one embodiment, the scalar values making up the cardiac vector are determined from the same relative predetermined features of the cardiac signals sensed in the same general cardiac location using the same general cardiac electrode configuration.
  • In one embodiment, the cardiac vector is compared to the classification vectors to determine whether the cardiac vector similar enough to one or more classification vectors to classify the cardiac complex. In one embodiment, a similarity coefficient is determined from each comparison of the cardiac vector and the one or more classification vectors. Based on this similarity coefficient, the cardiac complex is classified as the predetermined cardiac condition when the cardiac complex similarity coefficient exceed a predetermined threshold. In one embodiment, a mean square error is used to determine the similarity coefficient. In one embodiment, the mean square error value is represented as Σ(Ai−Ci)[0062] 2≦X, where Ai represents the ith scalar value (A1-An) of the cardiac vector, Ci represents the ith scalar value (C1-Cn) of the classification vector and X is a predetermined threshold value. In one embodiment, the predetermined threshold value X defines the region or a neighborhood around the classification vector which is deemed to be sufficiently close to permit classifying the cardiac complex represented by the cardiac vector as a general class of cardiac complexes represented by the classification vector. Based on the comparison, the cardiac complex is classified at 340 as being a member of the group represented by one or more classification vectors if possible.
  • In an additional embodiment, prior to comparing the cardiac vector to the classification vectors, the cardiac vector is aligned, or coordinated with, each of the classification vectors. In one embodiment, the cardiac vector and the classification vectors include element positions (A[0063] 1 and C1 are in the first element position, A2 and C2 are in the second element position, etc.) which are occupied by the scalar values. The cardiac vector and a classification vector are aligned around the scalar values in the same element position (i.e., a coordinating element position) in both the cardiac vector and the classification vector.
  • In one embodiment, the process of aligning the cardiac vector and the classification vector involves adjusting each scalar value of the cardiac vector so one of the element positions of the cardiac vector equals a scalar value in a corresponding element position in a classification vector. So, when the scalar values in the vectors are the time of occurrence of features in different channels, the vectors are aligned by add or subtract an appropriate numerical value to all the elements of the cardiac vector (e.g., the scalar values in the cardiac vector) so that the scalar value in the coordinating element position of the cardiac vector has the same numerical value as the coordinating element position of the classification vector. [0064]
  • In one embodiment of aligning a cardiac vector and a classification vector, a cardiac complex is sensed two or more cardiac channels, from which a cardiac vector A=[A[0065] 1, A2, A3, A4] is determined. In this embodiment, the elements of the vector are times at which the repeatably identifiable features of the cardiac complex occurred in the two or more cardiac channels. One or more classification vectors are provided having the general form C=[C1, C2, C3, C4]. In one embodiment, the cardiac vector is aligned, or coordinated, around the same element position (the coordinating element) with each classification vector the cardiac vector is compared with. In one embodiment, the coordinating element is the first position in the cardiac vector and the classifying vector, A1 and C1. A numerical value Y is added to, or subtracted from, the value of A1 so that A1 equals C1. So, A1+Y=C1, where Y can have either a positive or a negative numerical value. In addition to modifying the value of A1 with Y, Y is also added to the remaining elements of the cardiac vector. So, a cardiac vector aligned with a classification vector has the form Aa=[A1+Y, A2+Y, A3+Y, A4+Y], where A1+Y=C1 of the classification vector C =[C1, C2, C3, C4]. After the cardiac vector has been aligned with the classification vector, the elements of the vectors, excluding the coordinating elements, are compared. This means that for the present example, the classification vector Aa=[A2+Y, A3+Y, A4+Y] would be compared to the classification vector C=[C2, C3, C4]. Finally, the cardiac vector can be aligned with a classification vector around any element (e.g., A1/C1, A2/C2, etc.) in the pair of vectors.
  • As previously discussed, the present subject matter uses two or more electrogram channels in a process of analyzing and classifying cardiac complexes. In one embodiment, a first cardiac signal and a second cardiac signal are sensed over a first electrogram channel and a second electrogram channel, respectively. During a tachycardia episode, a cardiac complex is detected in the first cardiac signal and the second cardiac signal. The morphology of the first cardiac signal and the second cardiac signal representing the cardiac complex can then be compared to template cardiac complexes. Based on this comparison, the cardiac complex can be classified as being representative of one or more predetermined cardiac rhythm states. Predetermined cardiac rhythm states can include, but are not limited to, arrhythmic or non-arrhythmic, normal sinus rhythm (NSR), ventricular tachycardia and/or supraventricular tachycardia cardiac rhythm states. [0066]
  • In an additional embodiment, the process of comparing the morphology of the cardiac complex to a template cardiac complex includes the act of aligning, or coordinating, the cardiac complex sensed in a first cardiac signal of the two or more cardiac signals with a template cardiac complex having been derived from cardiac complexes sensed in the first cardiac signal. Alternatively, the morphology of the cardiac complex sensed in the two or more cardiac channels is compared to the morphology of the template cardiac complex which was derived from cardiac complexes sensed in the two or more cardiac channels. [0067]
  • In one embodiment, a first cardiac signal and a second cardiac signal are sensed over a first electrogram channel and a second electrogram channel, respectively. During a tachycardia episode, a cardiac complex is detected in the first cardiac signal and the second cardiac signal. In one embodiment, the cardiac complex detected in the first cardiac signal is aligned, or coordinated, with a first normal sinus rhythm (NSR) representative complex. In one embodiment, the first NSR representative complex is the template cardiac complex which, in the present embodiment, was derived from normal sinus rhythm cardiac complexes detected in the first cardiac signal. [0068]
  • Once the cardiac complex from the first cardiac signal has been aligned with the first NSR representative complex, the cardiac complex from the second cardiac signal is morphologically compared to the second NSR representative complex. In the present embodiment, this comparison is then used to classify the cardiac complex as either a complex representative of an arrhythmic episode or of a non-arrhythmic episode. [0069]
  • Through the process of first aligning the cardiac complex sensed in the first cardiac signal with the first NSR representative complex, the comparison of the cardiac complex as sensed in the second cardiac signal to the second NSR representative complex not only uses the relative morphologies of the cardiac complexes in classifying the cardiac complex, but also takes into consideration the relative time the cardiac complex detected in the first cardiac signal occurred with respect to the cardiac complex detected in the second cardiac signal. The relative time between the sensed cardiac complex in the first cardiac signal and the second cardiac signal helps to further accentuates morphological differences in the cardiac complex and template cardiac complex. [0070]
  • Referring now to FIG. 5 of the drawings, there is shown one embodiment of a medical device system suitable for implementing the present subject matter. By way of example only, and not by limitation, the medical device system includes an implantable cardiac defibrillator [0071] 500 electrically and physically coupled to at least one catheter 502. In one embodiment, the catheter 502 is an intracardiac catheter which includes at least a first cardiac electrode and a second cardiac electrode.
  • The catheter [0072] 502 is implanted in a human body 504 with portions of the catheter 502 inserted into a heart 506 to detect and analyze electric cardiac signals produced by the heart 506 and to provide electrical energy to the heart 506 under certain predetermined conditions to treat cardia arrhythmias, including ventricular fibrillation, of the heart 506.
  • In one embodiment, the catheter [0073] 502 is an endocardial lead adapted to be releasably attached to the cardiac defibrillator 500. The catheter 502 has an elongate body with a proximal end 508 and a distal end 510, and includes at least a first cardiac electrode and a second cardiac electrode. In one embodiment, the catheter 502 has a pacing electrode 512 located at, or adjacent, the distal end 510 of the catheter 502. Additional pacing electrodes can also be included on the catheter 502 to allow for bipolar sensing and pacing with the pacing electrode 512. In addition, other pacing and sensing electrode configurations are also possible. The catheter 502 also includes one or more defibrillation electrodes. In one embodiment, the catheter 502 has a first defibrillation electrode 514 and a second defibrillation electrode 516, where the defibrillation electrodes have a coil construction as is known.
  • In addition to the catheter configuration shown in FIG. 5, it is considered within the scope of the present subject matter that additional catheters positioned in or around the ventricular and/or the atrial chambers can be added to the cardiac defibrillator [0074] 500 to allow for additional cardiac signals to be sensed (e.g., two or more cardiac signals). Thus, it would be possible to sense cardiac signals from any combination or subcombination of ventricular, right ventricular, left ventricular, atrial, right atria and/or left atria locations. These signals can include, but are not limited to, far-field and/or near-field cardiac signals.
  • Referring now to FIG. 6, there is shown an embodiment of a block diagram of a cardiac defibrillator [0075] 500. The cardiac defibrillator 500 includes control system circuitry 600 for receiving cardiac signals from a heart 506 and delivering electrical energy to the heart 506. The control system circuitry 600 includes a sensing system 602 attached to at least one catheter. The sensing system 602 includes terminals labeled with reference numbers 604, 608, and 612 for connection to electrodes attached to the surface of the catheter 502. In one embodiment, the pacing electrode 512 is electrically connected to terminal 604 and to the control system circuitry 600 through an electrically insulated conductor provided within the elongate body of the catheter 502. The first defibrillation electrode 514 and the second defibrillation electrode 516 are connected to terminals 608 and 612, respectively, and to the control system circuitry 600 through electrically insulated conductors provided within the elongate body of the catheter 502.
  • In one embodiment, the control system circuitry [0076] 600 of the cardiac defibrillator 500 is encased and hermetically sealed in a housing 530 suitable for implanting in a human body as are known in the art. A connector block 532 (FIG. 5) is additionally attached to the housing 530 of the cardiac defibrillator 500 to allow for the physical and the electrical attachment of the catheter 502 and the electrodes to the cardiac defibrillator 500 and the encased control system circuitry 600.
  • In one embodiment, the control system circuitry [0077] 600 of the cardiac defibrillator 500 is a programmable microprocessor-based system, with a microprocessor 616 and a memory circuit 620 which contains parameters for various pacing, defibrillation, and sensing modes and stores data indicative of cardiac signals received by the control system circuitry 600. A transmitter circuit 624 is additionally coupled to the control system circuitry 600 and the memory circuit 620 to allow the cardiac defibrillator 500 to communicate with and receive programming instructions and transmit data to and from a programmer unit 228 as is known in the art. In one embodiment, the transmitter circuit 624 and the programmer unit 628 use a wire loop antenna 632 and a radio frequency telemetric link, as is known in the art, to receive and transmit signals and data to and from the programmer unit 628 and the control system circuitry 600. In this manner, programming commands or instructions are transferred to the microprocessor 616 of the cardiac defibrillator 500 after implant, and stored cardiac data pertaining to sensed arrhythmic episodes within the heart 506 and subsequent therapy, or therapies, applied to correct the sensed arrhythmic event are transferred to the programmer unit 628 from the cardiac defibrillator 500.
  • In the present embodiment, the medical device system senses at least a first signal and a second signal, both of which are representative of electrical cardiac activity. The first signal and the second signal each contain cardiac complexes which represent at least a portion of the cardiac cycle. Based on the embodiment shown in FIG. 5, the first signal is a rate signal sensed within the right ventricle chamber of the heart and the second signal is a morphology signal sensed across at least a portion of the ventricular region of the heart. In an alternative embodiment, the first and second signals can be rate and morphology signals sensed in a supraventricular region of the heart. Alternatively, cardiac electrodes and/or catheters can be provided to allow for the first signal to be a morphology signal and the second signal to be a rate signal. [0078]
  • In the embodiment shown in FIG. 5, the pacing electrode [0079] 512 is included in a near-field channel which senses near-field signals or rate-signals of the heart 506. The near-field sensing channel includes the pacing electrode 512 which is coupled to a sense amplifier 630 within the sensing system 602. In one embodiment, the housing 530 of the cardiac defibrillator 500 is coupled to the sense amplified 630 at 634 to allow for unipolar cardiac rate sensing between the pacing electrode 512 and the housing 530 of the cardiac defibrillator 500. In an alternative embodiment, the cardiac rate signal is sensed using pacing electrode 512 and the first defibrillation electrode 514.
  • The output of the sense amplifier [0080] 630 is shown connected to an R-wave detector 636. The R-wave detector 636 serves to sense and amplify cardiac signals, including cardiac complexes, sensed from the heart, and apply signals indicative thereof to a signal feature comparison circuit 638. The signal feature comparison circuit 638 is coupled to the microprocessor 616. Among other things, microprocessor 616 responds to signals from the R-wave detector 636 by providing pacing signals to a pace output circuit 640, as needed according to the programmed pacing mode. In one embodiment, the pace output circuit 640 provides output pacing signals to terminals 604 and 634, which connect to the pacing electrode 512 and the housing 530 of the cardiac defibrillator 500, for cardiac pacing.
  • Referring again to the embodiment in FIG. 5, far-field or morphology signals are sensed through the first defibrillation electrode [0081] 514 and the second defibrillation electrode 516. The first defibrillation electrode 514 and the second defibrillation electrode 516 are used in a far-field sensing channel, where the first defibrillation electrode 514 and the second defibrillation electrode 516 are coupled to a sense amplifier 644 to sense far-field signals, which include cardiac complexes, from the heart. In an alternative embodiment, far-field signals are sensed between the first defibrillation electrode 514, the second defibrillation electrode 516 and the housing 530. The output of the sense amplifier 644 is coupled to a morphology analyzer circuit 648.
  • The morphology analyzer circuit [0082] 648 receives and processes the cardiac complexes detected within the cardiac signals. In one embodiment, the morphology analyzer circuit 648 receives cardiac signals, including cardiac complexes representative of the cardiac cycle from the sensing system. Cardiac complexes analyzed by the morphology analyzer circuit 648 can include detected P-waves, QRS-complexes, and R-waves. In one embodiment, the morphology analyzer circuit 648 includes an analog filter for filtering cardiac signal noise sensed by the electrodes. The cardiac signals are then bandlimited before arriving at an analog-to-digital filter which converts the analog signals into digital signals suitable for processing. In an alternative embodiment, the cardiac signals are filtered through an analog peak detector to extract the maximum and minimum cardiac signal values for each sensed cardiac complex.
  • In processing sensed cardiac complexes, the morphology analyzer circuit [0083] 648 windows a cardiac complex sensed in two or more cardiac signals. In one embodiment, the morphology analyzer circuit 648 locates and extracts information from one or more predetermined features of sensed cardiac complexes. As previously discussed, the type of information extracted by the morphology analyzer circuit 648 can include the time of occurrence of a predetermined feature and the amplitude value of a predetermined feature. In one embodiment, the predetermined features include repeatably identifiable portions of cardiac complexes which are repeatably identifiable in subsequent cardiac complexes. For example, features include a maximum deflection of the cardiac complex, a beginning of a cardiac complex as indicated by a predetermined deviation of the cardiac signal from a baseline signal, and an ending of a cardiac complex as indicated by a return of the first cardiac signal to a baseline signal. In one embodiment, the features are selectively programmed into the medical device system.
  • A template generator circuit [0084] 650 is coupled to the sensing system 602. The template generator circuit 650 receives information from the morphology analyzer 648. In one embodiment, the information received from the morphology analyzer 648 includes the information extracted from the two or more cardiac signals by the morphology analyzer circuit 648. In one embodiment, the template generator circuit 650 creates the numerical representation of sensed cardiac complexes. The template generator circuit 650 then creates the “N” dimensional cardiac complex vector from these values as previously described. In addition, the template generator circuit 650 is also used to create the one or more classification vectors from a patient's own cardiac complexes as previously described.
  • In an alternative embodiment, the template generator circuit [0085] 650 receives at least the first signal and the second signal sensed from the heart 506. In one embodiment, the template generator circuit 650 determines a first normal sinus rhythm (NSR) representative complex and a second NSR representative complex from a plurality cardiac complexes sensed during normal sinus rhythm. In one embodiment, the first NSR representative complex and the second NSR representative complex are averages of cardiac complexes sensed in the first signal and the second signal during a patient's normal sinus rhythm. In an alternative embodiment, the first NSR representative complex and the second NSR representative complex are median values of the cardiac complexes sensed in the first signal and the second signal during a patient's normal sinus rhythm.
  • After the cardiac signals and information relating to the cardiac complexes in the cardiac signals have been processed by the morphology analyzer circuit [0086] 648 and the template generator circuit 650, the signals are received by a signal feature comparison circuit 638. The signal feature comparison circuit 638 uses information contained in the cardiac signals to analyze and classify sensed cardiac complexes.
  • In one embodiment, the signal feature comparison circuit [0087] 638 uses the one or more classification vectors which are stored in memory 620. The signal feature comparison circuit 638 compares the cardiac complex vector to the one or more classification vectors, as previously described, to classify the cardiac complex represented by the cardiac complex vector. In an additional embodiment, the signal feature comparison circuit 638 can also align the cardiac vectors with classification vectors prior to comparing the vectors when programmed to perform this function.
  • In an alternative embodiment, as cardiac complexes are sensed using the first cardiac signal and the second cardiac signal, the signal feature comparison circuit [0088] 638 aligns the predetermined feature in the cardiac complex monitored in the first signal with the predetermined feature on the first NSR representative complex. Once the predetermined features in the cardiac complex from the first signal is aligned with the corresponding predetermined feature in the first NSR representative complex, the morphology analyzer circuit 648 compares the cardiac complex monitored in the second signal to the second NSR representative complex to determine whether the cardiac complex is an arrhythmic complex. In one embodiment, the morphology analyzer circuit 648 compares the morphology of the cardiac complex monitored in the second signal to the second NSR representative complex to determine whether the cardiac complex is an arrhythmic complex.
  • In an alternative embodiment, the morphology analyzer [0089] 648 can also compare the morphology of a cardiac complex sensed in two or more cardiac channels to one or more template cardiac complexes to classify the cardiac complex. In one embodiment, the template cardiac complexes are determined from cardiac complexes sensed in the two or more cardiac channels which are subsequently used to sense cardiac complexes to be classified. Alternatively, the template cardiac complexes are determined from cardiac complexes sensed from a patient population experiencing the cardiac state for which template cardiac complexes are developed. In one embodiment, the cardiac states for which template cardiac complexes can be developed include cardiac rhythms where the left chamber and the right chamber of the ventricles or atria differ by about 20 milliseconds or more, premature ventricular contractions, ischemia, predetermined or custom patterns or classes of complexes predetermined by a physician, arrhythmia, non-arrhythmia, ventricular or supraventricular tachycardia.
  • In one embodiment, as sensed cardiac complexes are sensed and classified, the microprocessor [0090] 616 determines the percentage of classified cardiac complexes for a plurality of sensed cardiac complexes. In one embodiment, the microprocessor 616 determines the percentage of cardiac complexes classified as arrhythmic complexes for a plurality of cardiac complexes sensed during an arrhythmic episode. In one embodiment, once the percentage of classified cardiac complexes reaches a predetermined threshold for any one of the cardiac conditions or states programmed into the medical device system, the microprocessor 616 responds by providing signals to cardioversion/defibrillation output circuitry 652 to deliver either cardioversion or defibrillation therapy to the heart 506. Power to the cardiac defibrillator 500 is supplied by an electrochemical battery 656 that is housed within the cardiac defibrillator 500.
  • In addition to the catheter [0091] 502, it is possible to add additional electrodes, catheters and the accompanying required circuitry to the medical device system. For example, the cardiac defibrillator 500 can be equipped with electrodes on the surface of the housing 530 to sense surface like cardiac signals. In addition, the medical device system can further include an additional intracardiac catheter implanted in the supraventricular region of the heart. The additional intracardiac catheter includes at least one pacing electrode from which rate signals, or near field signals, from the atria are sensed and pacing pulses are delivered to pace the atrial chamber of the patient's heart. In an additional embodiment, the additional intracardiac catheter is implanted through the coronary sinus vein and down the great cardiac vein to position an electrode, such as a pacing electrode, adjacent to the left ventricular chamber of the heart.
  • In an alternative embodiment, the catheter [0092] 502 is implanted the supraventricular region of the heart for sensing or monitoring cardiac signals from the patient's atrial regions. In one embodiment, a pacing electrode at or adjacent the distal end of the intracardiac catheter is implanted in the coronary sinus vein to allow for rate signals to be sensed from the left atrium. In addition, far-field signals, or morphology signals, are sensed from the supraventricular region of the heart through the first defibrillation electrode and the second defibrillation electrode. In addition to implanting the catheter 502 in the supraventricular region of the heart, an additional atrial catheter can be implanted into the supraventricular region of the heart to allow for additional rate signals, or near-field signals, to be sensed along with the rate signals and morphology signals sensed with the catheter 502. Other intracardiac catheter arrangements and configurations known in the art are also possible and considered to be within the scope of the present system.
  • Referring now to FIG. 7, there is shown an additional embodiment of the present subject matter. At step [0093] 700, a cardiac complex is detected during a tachycardia episode in the first signal and the second signal. In one embodiment, tachycardia episodes include, but are not limited to, ventricular tachycardias and supraventricular tachycardias. In one embodiment, the medical device system analyzes at least the cardiac complexes detected in the first signal to determined the occurrence of a tachycardia episode which will be classified by the present subject matter.
  • In one embodiment, the first signal and the second signal detect the occurrence of cardiac cycles through either a near-field sensing channel or a far-field sensing channel as previously discussed. Cardiac complexes sensed in the first signal and the second signals can include the QRS-wave, the R-wave and/or the P-wave of the cardiac complex. This list, however, is not to be take in a limiting sense as it is recognized that other portions of the cardiac complex can also be sensed and used with the present subject matter. [0094]
  • As the cardiac complex is detected in the first signal and the second signal during the tachycardia episode, the first and second signal of the cardiac complex are windowed together so the cardiac complex in the first signal is positioned relative the cardiac complex in the second signal. In other words, the first signal and the second signal for each sensed tachycardiac cardiac complex are positioned relative each other according to their occurrence in time. [0095]
  • FIG. 8 shows an example of a cardiac complex having been windowed at [0096] 800. In the example, 804 shows a tachycardiac cardiac complex monitored on a near-field sensing channel, while 808 shows the cardiac complex monitored on a far-field sensing channel.
  • After the cardiac complex has been windowed, the first and second signals of the cardiac complex are positioned or aligned relative the first NSR representative complex and the second NSR representative complex. In one embodiment, the first and second NSR representative complexes are determined from a plurality of NSR cardiac complexes detected in the first signal and the second signal, respectively, using the same medical device system that is subsequently used to senses the cardiac complexes. In one embodiment, the first NSR representative complex and the second NSR representative complex are derived by averaging cardiac complexes detected in the first and second signals for the plurality of NSR cardiac complexes sensed from the patient. In an alternative embodiment, the first NSR representative complex and the second NSR representative complex are derived by taking a median of cardiac complexes detected in the first and second signals for the plurality of NSR cardiac complexes sensed from the patient. [0097]
  • In addition, the first NSR representative complex and the second NSR representative complex can be updated, either manually or automatically, to reflect changes in a patient's cardiac condition or in the medical device system. For example, the first NSR representative complex and the second NSR representative complex could change due to the type of drug or dosage of drugs being delivered to the patient and the cardiac disease state of the patient. Therefore, the system can recompute the first NSR representative complex and the second NSR representative complex at regular intervals based either on the physician's judgement or on the implantable medical devices assessment of the template. Additionally, a safe-check algorithm can be used in conjunction with any automatic updating procedure to ensure that only normal sinus rhythm complexes are used in updating the template. [0098]
  • At [0099] 720, the cardiac complex detected in the first signal is aligned with the first NSR representative complex. In one embodiment, the cardiac complex in the first signal and the first NSR representative complex are aligned around a predetermined feature located in the cardiac complexes. In one embodiment, the predetermined feature includes a repeatably identifiable section, or portion, of the detected cardiac complex that is common to the cardiac complex detected in the first signal and the first NSR representative complex. In one embodiment, the repeatably identifiable complex section common to the cardiac complex detected in the first signal and the first NSR representative complex is a maximum deflection of the first signal. In one embodiment, the maximum deflection is along an R-wave sensed in the cardiac complex detected in the first signal and in the first NSR representative complex.
  • In an alternative embodiment, the repeatably identifiable complex section common to the cardiac complex detected in the first signal and the first NSR representative complex is a predetermined deviation of the first signal from a baseline signal indicating a beginning of the cardiac complex and the first NSR representative complex. In an additional embodiment, the repeatably identifiable complex section common to the cardiac complex detected in the first signal and the first NSR representative complex is a return of the first signal to a baseline signal for each of the cardiac complex and the first NSR representative complex for a predetermined time period indicating an ending of the cardiac complex and the first NSR representative complex. [0100]
  • After the cardiac complex detected in the first signal has been aligned with the first NSR representative complex, the cardiac complex detected in the second signal is compared to the second NSR representative complex to determine whether the cardia complex is an arrhythmic complex. One way of determining whether the cardia complex is an arrhythmic complex is to compare the morphology of the second signal to the second NSR representative complex. In one embodiment, the second NSR representative complex has a second NSR morphology and the cardiac complex detected in the second signal has a second signal morphology. The second NSR morphology of the second NSR representative complex is then compared to the second signal morphology of the second signal to determine whether the cardia complex is an arrhythmic complex. A variety of techniques exist for morphologic analysis of sensed cardiac complexes. In one embodiment, the morphology of the cardiac complex sensed in second signal and the morphology of the second NSR representative complex are compared using a correlation waveform analysis, as is known in the art. In addition to correlation waveform analysis, other morphology comparison methods or methods of classifying cardiac complexes sensed during an arrhythmic episode. Additional morphology analysis techniques include amplitude distribution analysis and spectral analysis. Other morphology analysis techniques are known and are considered to be with the scope of the present subject matter. [0101]
  • By initially aligning the cardiac complex detected in the first signal with the first NSR representative complex, the time the cardiac complex detected in the second signal and the second NSR representative complex occurred relative the first signal with the first NSR representative complex become a factor in determining what portion of the second NSR representative complex is compared to the cardiac complex in the second signal. [0102]
  • FIG. 8 shows one embodiment of aligning the cardiac complex detected in the first signal with the first NSR representative complex. In [0103] 800 there is shown a window containing a cardiac complex detected in a first signal 804 and a second signal 808. In one embodiment, the first signal 804 is a near-field signal of an R-wave, and the second signal 808 is a far-field signal of a QRS-cardiac complex. In 812 there is shown a window containing a first NSR representative complex 816 and a second NSR representative complex 820. In the present example, the first NSR representative complex 816 is a near-field signal of an R-wave, and the second NSR representative complex 820 is a far-field signal of a QRS-cardiac complex.
  • As previously discussed, the morphology analyzer circuit [0104] 648 locates the predetermined feature in the cardiac complex detected in the first signal 804 and in the first NSR representative complex 816. The signal feature comparison circuit 638 then aligns the predetermined feature in the cardiac complex monitored in the first signal 804 with the predetermined feature on the first NSR representative complex 816. In FIG. 8, the cardiac complex 800 and the first NSR representative complex 812 are aligned around a maximum deflection 824 of the cardiac complexes 804 and 816. The signal feature comparison circuit 638 then compares the cardiac complex monitored in the second signal 808 to the second NSR representative complex 820 to determine whether the cardiac complex is an arrhythmic complex. As previously discussed, because the predetermined feature in the cardiac complex monitored in the first signal 804 has been aligned with the predetermined feature on the first NSR representative complex 816, the time the second signal 808 occurs relative the first signal 804 and the time the second NSR representative complex 820 occurs relative the first NSR representative complex 816 can be used to accentuate morphological differences between the complexes. So in one embodiment, the QRS-cardiac complex 828 in the second signal 808 is morphologically compared to a region 832 along the second NSR representative complex 820. Alternatively, the QRS-cardiac complex 834 in the second NSR representative complex 820 is morphologically compared to a region 836 along the second signal 808.
  • FIG. 9 shows an alternative embodiment of aligning a cardiac complex sensed during a tachycardia episode with a normal sinus rhythm template cardiac complex. In [0105] 900 there is shown a window of a first NSR representative complex 904 and a second NSR representative complex 908. In the present example, the first NSR representative complex 904 is a far-field signal of a QRS-cardiac complex, and the second NSR representative complex 908 is a near-field signal of an R-wave cardiac complex. In 912 there is shown a window of a cardiac complex sensed during a tachycardia episode, where the first signal 916 is a far-field signal of a QRS-cardiac complex and the second signal 920 is a near-field signal of an R-wave cardiac complex.
  • In the present embodiment, the cardiac complex [0106] 912 and the representative NSR complex 900 are aligned around the beginning, or the start, of the cardiac complexes 904 and 916. After the representative NSR complex and the tachycardiac cardiac complex have been aligned, the morphology of the second signal 920 is compared to the morphology of the second NSR representative complex 908 to determine whether the cardiac complex is an arrhythmic complex. In one embodiment, the R-wave cardiac complex 924 in the second signal 920 is morphologically compared to a region 928 along the second NSR representative complex 908. In an alternative embodiment, the R-wave cardiac complex 930 in the second NSR representative complex 908 is morphologically compared to a region 932 along the second signal 920.
  • In one embodiment, the present subject matter can classify a variety of cardiac complexes, including VT-complexes, SVT-complexes and NSR-complexes. Other classifications for the tachycardiac cardiac complex are known and are considered within the scope of the present invention. [0107]
  • FIG. 10 shows an additional embodiment of the present subject matter. At [0108] 1000, a first signal and a second signal representative of electrical cardiac activity are sensed from a patient. In one embodiment, each of the signals include cardiac complexes representative of cardiac cycles. At 1010, a plurality normal sinus rhythm (NSR) cardiac complexes are detected in the first signal and the second signal. In one embodiment, the medical device system determines the first NSR representative complex from the plurality of NSR cardiac complexes detected in the first signal and determines the second NSR representative complex from the plurality of NSR cardiac complexes detected in the second signal. The first and second NSR representative complexes are then stored in the memory of the medical device system.
  • At [0109] 1020, cardiac complexes monitored in at least the first signal are analyzed by the medical device system to detect the onset of a tachycardia episode. If no tachycardia episode is detected, the system continues to sense cardiac signals and analyzes them for the occurrence of a tachycardia episode. In one embodiment, the occurrence of a tachycardia episode is based on the cardiac rate, where a tachycardia episode is declared when the cardiac rate exceeds a predetermined threshold. In one embodiment, the predetermined threshold is a cardiac rate of between 150 and 180 beats per minute. Other systems of determining the occurrence of a tachycardia episode are known and are considered to be within the scope of the present system.
  • When a tachycardia episode is detected the system then proceeds to [0110] 1030. At 1030, the first signal and the second signal are monitored for the occurrence of cardiac complexes. The detected cardiac complexes are analyzed, or processed, so that each cardiac complex is classified as either an arrhythmic complex or a non-arrhythmic complex. In processing each cardiac complex at 1030, the predetermined feature is located in the cardiac complex detected in the first signal and the first NSR representative complex. As previously discussed, the predetermined feature includes a repeatably identifiable portion of cardiac complexes.
  • At [0111] 1040, the predetermined feature on the cardiac complex sensed in the first signal is then aligned with the corresponding first feature found on the first NSR representative complex. In one embodiment, the predetermined feature on the first NSR representative complex has been previously located and stored in the memory of the medical device system. After the predetermined feature on both the cardiac complex sensed in the first signal and the first NSR representative complex have been aligned, the cardia complex sensed in the second signal is compared to the second NSR representative complex at 1050. In one embodiment, the second NSR representative complex has a second NSR morphology and the cardiac complex detected in the second signal has a second signal morphology, where the second NSR morphology is compared to the second signal morphology to determine whether the cardia complex is an arrhythmic complex. Based on the comparison, the cardiac complex is classified as either an arrhythmic complex or as a non-arrhythmic complex at 1060.
  • After making a determination as to whether a cardiac complex is an arrhythmic complex or a non-arrhythmic complex, a percentage of arrhythmic complexes is determined at [0112] 1070. At 1080, the calculated percentage of arrhythmic complexes is compared to a predetermined percentage threshold. In one embodiment, therapy for treating the condition associated with the arrhythmic complexes being sensed is applied to the patient's heart at 1090 when the percentage of arrhythmic complexes exceeds the predetermined percentage threshold. If the percentage of arrhythmic complexes does not exceed the predetermined percentage threshold, the system returns to 1030. In one embodiment, the predetermined percentage threshold is a programmable value in the range of 40 to 60 percent, where a value of approximately 50 percent is an acceptable value.
  • FIG. 11 shows an additional embodiment of the present subject matter. At [0113] 1100, a first signal and a second signal representative of electrical cardiac activity are sensed from a patient, where the first signal and the second signal each include at least a portion of a QRS-complex. At 1110, a plurality normal sinus rhythm (NSR) cardiac complexes are detected in the first signal and the second signal. The medical device system determines the first NSR representative complex from the at least a portion of the QRS-complex in each of the plurality of NSR cardiac complexes detected in the first signal and the second NSR representative complex from the at least a portion of the QRS-complex in each of the plurality of NSR cardiac complexes detected in the second signal. The first and second NSR representative complexes are then stored in the memory of the medical device system.
  • At [0114] 1120, cardiac complexes monitored in at least the first signal are analyzed by the medical device system to detect the onset of a tachycardia episode. If no tachycardia episode is detected, the system continues to sense cardiac signals and analyzes them for the occurrence of a tachycardia episode. In one embodiment, the occurrence of a tachycardia episode is based on the ventricular cardiac rate, where a tachycardia episode is declared when the ventricular cardiac rate exceeds a predetermined threshold. In one embodiment, the predetermined threshold is a ventricular cardiac rate of between 150 and 180 beats per minute. Other systems of determining the occurrence of a tachycardia episode are known and are considered to be within the scope of the present system.
  • When a tachycardia episode is detected the system then proceeds to [0115] 1130. At 1130, the first signal and the second signal are monitored for the occurrence of cardiac complexes. The detected cardiac complexes are analyzed, or processed, so that each cardiac complex is classified as either a ventricular tachycardia complex or a non-ventricular tachycardia complex. In processing each cardiac complex at 1130, the predetermined feature is located in the cardiac complex detected in the first signal and the first NSR representative complex. As previously discussed, the predetermined feature includes a repeatably identifiable portion of cardiac complexes.
  • At [0116] 1140, the predetermined feature on the cardiac complex sensed in the first signal is then aligned with the corresponding first feature found on the first NSR representative complex. In one embodiment, the predetermined feature on the first NSR representative complex has been previously located and stored in the memory of the medical device system. After the predetermined feature on both the cardiac complex sensed in the first signal and the first NSR representative complex have been aligned, the cardia complex sensed in the second signal is compared to the second NSR representative complex at 1150. In one embodiment, the second NSR representative complex has a second NSR morphology and the cardiac complex detected in the second signal has a second signal morphology, where the second NSR morphology is compared to the second signal morphology to determine whether the cardia complex is a ventricular tachycardia complex or a non-ventricular tachycardia complex. Based on the comparison, the cardiac complex is classified as either a ventricular tachycardia complex or a non-ventricular tachycardia complex at 1160.
  • After making a determination as to whether a cardiac complex is a ventricular tachycardia complex or a non-ventricular tachycardia complex, a percentage of ventricular tachycardia complexes is determined at [0117] 1170. At 1180, the calculated percentage of ventricular tachycardia complexes is compared to a predetermined percentage threshold. In one embodiment, therapy for treating a ventricular tachycardia is applied to the patient's heart at 1190 when the percentage of ventricular tachycardia complexes exceeds the predetermined percentage threshold. If the percentage of ventricular tachycardia complexes does not exceed the predetermined percentage threshold, the system returns to 1130. In one embodiment, the predetermined percentage threshold is a programmable value in the range of 40 to 60 percent, where a value of approximately 50 percent is an acceptable value.
  • FIG. 12 shows an additional embodiment of the present subject matter. At [0118] 1200, a first cardiac signal and a second cardiac signal representative of electrical cardiac activity are sensed and monitored from a patient. In one embodiment, the first cardiac signal and the second cardiac signal are monitored from a first cardiac region and a second cardiac region, respectively. At 1210, cardiac complexes are detected in the first cardiac signal and the second cardiac signal. As the cardiac complexes are sensed, template morphologies are developed for cardiac conditions exhibited by the patient. In one embodiment, as the patient experiences a cardiac condition (such as a ventricular tachycardia or supraventricular tachycardia) the cardiac complexes are recorded. In one embodiment, the system can then use the recorded cardiac complexes to develop a template morphology for the cardiac condition.
  • In one embodiment, the template morphology is comprised of a first template morphology and a second template morphology. In one embodiment, the first template morphology is derived from cardiac complexes monitored in the first cardiac signal sensed from approximately the first cardiac region and the second template morphology is derived from cardiac complexes monitored in the second cardiac signal sensed from approximately the second cardiac region. In an alternative embodiment, the first template morphology and the second template morphology for each cardiac condition of interest are developed through groups of patient data and programmed into the memory of the medical device system. The template cardiac complexes are then stored in the memory of the medical device system. [0119]
  • In one embodiment, the patient's cardiac complexes are monitored and analyzed by the medical device system. In one embodiment, the cardiac complexes are monitored for the onset of a tachycardia event. In an alternative embodiment, the cardiac complexes are monitored to detect the occurrence of a predetermined class or type of cardiac complex (e.g., PVCs, ischemic complexes). In one embodiment, to determine the occurrence of the predetermined class of cardiac complexes, the cardiac complexes sensed in the cardiac signals are morphologically compared to the template cardiac complexes. [0120]
  • For the present embodiment, the morphology of the cardiac complex in the first cardiac signal is compared to the first template morphology at [0121] 1220. At 1230, the morphology of the cardiac complex in the second cardiac signal is compared to the second template morphology of a cardiac condition template morphology. Based on the comparison, the sensed cardiac complexes are then classified as either belonging to or not belonging to one or more of the classes of cardiac complexes represented by the template cardiac complexes at 1240. After classifying each cardiac complex, the medical device system can retain the sensed cardiac complexes in memory. In addition, a percentage of the classified complexes is determined at 1070.
  • In an additional embodiment, a third cardia signal containing the cardiac complex can be monitored. A third template morphology can be developed in the same manner as described for the first and second template morphologies. The morphology of the cardiac complex in the third cardiac signal is then compared to a third template morphology. So, the cardiac complex can be classified based on the comparison of the morphology of the cardiac complex in the first cardiac signal, the second cardiac signal and the third cardiac signal to the first template morphology, the second template morphology and the third template morphology. [0122]

Claims (51)

What is claimed is:
1. A method, comprising:
monitoring two or more cardiac signals representative of electrical cardiac activity;
detecting a cardiac complex in each of the two or more cardiac signals;
comparing a morphology of the cardiac complex in each of the two or more cardiac signals to the morphology of a template cardiac complex; and
classifying the cardiac complex based on the comparison of the morphology of the cardiac complex in each of the two or more cardiac signals to the morphology of the template cardiac complex.
2. The method of claim 1, wherein monitoring two or more cardiac signals includes monitoring a first signal and a second signal representative of electrical cardiac activity;
analyzing the at least the first signal to detect a tachycardia episode;
when the tachycardia episode is detected, detecting the cardiac complex in the first signal and the second signal;
wherein comparing the morphology includes locating a predetermined feature in the cardiac complex detected in the first signal and a first NSR representative complex, wherein the predetermined feature includes a repeatably identifiable complex section common to the cardiac complex detected in the first signal and the first NSR representative complex;
aligning the predetermined feature in the cardiac complex detected in the first signal and the first NSR representative complex; and
wherein classifying the cardiac complex based on the comparison includes comparing the cardiac complex detected in the second signal to a second NSR representative complex to determine whether the cardia complex is an arrhythmic cardiac complex.
3. The method of claim 2, including detecting a plurality of normal sinus rhythm (NSR) cardiac complexes in the first signal and the second signal;
determining the first NSR representative complex from the plurality of NSR cardiac complexes detected in the first signal; and
determining the second NSR representative complex from the plurality of NSR cardiac complexes detected in the second signal.
4. The method of claim 2, where the repeatably identifiable complex section common to the cardiac complex detected in the first signal and the first NSR representative complex is a maximum deflection of the first signal.
5. The method of claim 4, where the maximum deflection is along an R-wave sensed in the cardiac complex detected in the first signal and in the first NSR representative complex.
6. The method of claim 2, where the repeatably identifiable complex section common to the cardiac complex detected in the first signal and the first NSR representative complex is a predetermined deviation of the first signal from a baseline signal indicating a beginning of the cardiac complex and the first NSR representative complex.
7. The method of claim 2, where the repeatably identifiable complex section common to the cardiac complex detected in the first signal and the first NSR representative complex is a return of the first signal to a baseline signal for each of the cardiac complex and the first NSR representative complex for a predetermined time period indicating an ending of the cardiac complex and the first NSR representative complex.
8. The method of claim 2, where the second NSR representative complex has a second NSR morphology and the cardiac complex detected in the second signal has a second signal morphology, and comparing the cardiac complex detected in the second signal to the second NSR representative complex includes comparing the second NSR morphology to the second signal morphology to determine whether the cardia complex is an arrhythmic complex.
9. The method of claim 8, where comparing the second NSR morphology to the second signal morphology includes utilizing a correlation waveform analysis algorithm.
10. The method of claim 2, where sensing the first signal includes sensing electrical cardiac activity through a far-field sensing channel, and sensing the second signal includes sensing electrical cardiac activity through a near-field sensing channel.
11. The method of claim 2, where sensing the first signal includes sensing electrical cardiac activity through a near-field sensing channel, and sensing the second signal includes sensing electrical cardiac activity through a far-field sensing channel.
12. The method of claim 3, including detecting at l east a portion of a QRS-complex in each of the plurality of NSR cardiac complexes;
determining the first NSR representative complex from the at least a portion of the QRS-complex in each of the plurality of NSR cardiac complexes detected in the first signal;
determining the second NSR representative complex from the at least a portion of the QRS-complex in each of the plurality of NSR cardiac complexes detected in the second signal;
detecting a QRS-complex in the cardiac complex,
comparing the second NSR morphology to the second signal morphology to determine whether the cardia complex is a ventricular tachycardia complex;
determining a percentage of the ventricular tachycardia complex in a plurality of cardiac complexes sensed during the tachycardia episode; and
applying therapy for treating a ventricular tachycardia when the percentage of the ventricular tachycardia complex exceeds a predetermined percentage threshold.
13. The method of claim 12, where the predetermined percentage threshold is 50 percent.
14. The method of claim 1, wherein comparing comprises locating at least one predetermined feature in the cardiac complex for each of the two or more cardiac signals, wherein the at least one predetermined feature includes a repeatably identifiable complex portion;
generating a scalar value as a function of a position of the at least one predetermined feature for each of the two or more cardiac signals;
using the scalar values to create a cardiac vector, where the cardiac vector represents the cardiac complex; and
classifying comprises comparing the cardiac vector to one or more classification vectors, where each of the one or more classification vectors represents a predetermined cardiac condition;
determining a similarity coefficient from each comparison of the cardiac vector and the one or more classification vectors; and
classifying the cardiac complex as the predetermined cardiac condition when the cardiac complex similarity coefficient exceed a predetermined threshold.
15. The method of claim 14, where detecting the cardiac complex includes isolating the cardiac complex in an analysis window.
16. The method of claim 14, where the at least one predetermined feature in the cardiac complex is a maximum deflection of the two or more cardiac signals.
17. The method of claim 14, where the at least one predetermined feature in the cardiac complex is a predetermined deviation of the two or more cardiac signals from a baseline signal indicating a beginning of the cardiac complex.
18. The method of claim 14, where the at least one predetermined feature in the cardiac complex is a return of the two or more cardiac signal to a baseline signal for a predetermined time period indicating an ending of the cardiac complex.
19. The method of claim 14, where the scalar value is a time the at least one predetermined feature of the cardiac complex occurred.
20. The method of claim 14, where the scalar value is a difference in time between the occurrence of two of the at least one predetermined feature.
21. The method of claim 14, where the scalar value is a magnitude of the position of the at least one predetermined feature for each of the two or more cardiac signals.
22. The method of claim 14, where determining a similarity coefficient comprises determining a mean square error value from each comparison of the cardiac vector and the one or more classification vectors.
23. The method of claim 14, including aligning the cardiac vector with each of the one or more classification vectors prior to comparing the cardiac vector, where the cardiac vector includes element positions occupied by the scalar values, and each of the one or more classification vectors includes an equal number of element positions as the element positions of the cardiac vector, wherein the element positions of the one or more classification vectors are occupied by scalar values representing the predetermined cardiac condition, and wherein the cardiac vector is aligned with a classification vector of the one or more classification vectors by adjusting each scalar value of the cardiac vector so one of the element positions of the cardiac vector equals a scalar value in a corresponding element position in a classification vector.
24. The method of claim 1, wherein monitoring two or more cardiac signals includes monitoring a first cardiac signal and a second cardiac signal;
detecting the cardiac complex includes detecting the cardiac complex in each of the first cardiac signal and the second cardiac signal;
comparing the morphology includes comparing the morphology of the cardiac complex in the first cardiac signal to a first template morphology and comparing the morphology of the cardiac complex in the second cardiac signal to a second template morphology; and
classifying the cardiac complex includes classifying the cardiac complex based on the comparison of the morphology of the cardiac complex in the first cardiac signal and the second cardiac signal to the first template morphology and the second template morphology.
25. The method of claim 24, where monitoring the first cardiac signal and the second cardiac signal comprises monitoring the first cardiac signal from a first cardiac region and the second cardiac signal from a second cardiac region.
26. The method of claim 24, including deriving the first template morphology from cardiac complexes sensed from approximately the first cardiac region.
27. The method of claim 24, including deriving the second template morphology from cardiac complexes sensed from approximately the second cardiac region.
28. The method of claim 24, including:
monitoring a third cardiac signal;
detecting the cardiac complex in the third cardiac signal;
comparing the morphology of the cardiac complex in the third cardiac signal to a third template morphology; and
classifying the cardiac complex based on the comparison of the morphology of the cardiac complex in the first cardiac signal, the second cardiac signal and the third cardiac signal to the first template morphology, the second template morphology and the third template morphology.
29. The method of claim 28, where monitoring the third cardiac signal comprises monitoring the third cardiac signal from a third cardiac region.
30. The method of claim 29, including deriving the third template morphology from cardiac complexes sensed from approximately the third cardiac region.
31. A system, comprising:
at least one catheter having at least a first cardiac electrode and a second cardiac electrode;
a sensing system attached to the first cardiac electrode and the second cardiac electrode, wherein the sensing system senses a first signal and a second signal representative of electrical cardiac activity;
a morphology analyzer circuit coupled to the sensing system, wherein the morphology analyzer circuit locates a position of at least one predetermined feature in the morphology of the cardiac complex in the first signal and the second signal and generates two or more scalar values as a function of the position of the at least one predetermined feature for each of the first signal and the second signal;
a template generator coupled to the morphology analyzer, wherein the template generator circuit creates a cardiac complex vector from the two or more scalar values generated by morphology analyzer circuit; and
a signal feature comparison circuit coupled to the morphology analyzer circuit and the template generator circuit, wherein the signal feature comparison circuit compares the cardiac complex vector to one or more classification vectors to classify the cardiac complex.
32. The system of claim 31, wherein the at least one predetermined feature is a maximum deflection of the first signal and the second signal.
33. The system of claim 31, wherein the at least one predetermined feature is a predetermined deviation of the of the first signal and the second signal from a baseline signal indicating a beginning of the cardiac complex.
34. The system of claim 31, wherein the at least one predetermined feature is a return of the first signal and the second signal to a baseline signal for a predetermined time period indicating an ending of the cardiac complex.
35. The system of claim 31, wherein the scalar value is a time the at least one predetermined feature in the morphology of the cardiac complex occurred.
36. The system of claim 31, wherein the scalar value is a difference in time between the occurrence of a first predetermined feature and a second predetermined feature.
37. The system of claim 31, wherein the scalar value is a magnitude of the position of the at least one predetermined feature of the first signal and the second signal.
38. The system of claim 31, wherein the signal feature comparison circuit determines a similarity coefficient for each comparison of the cardiac vector to the one or more classification vectors, and classifies the cardiac complex as a predetermined cardiac condition when the similarity coefficient exceed a predetermined threshold.
39. The system of claim 31, wherein the signal feature comparison circuit aligns the cardiac vector with each of the one or more classification vectors prior to comparing the vectors, where the cardiac vector includes element positions occupied by the scalar values, and each of the one or more classification vectors includes an equal number of element positions as the element positions of the cardiac vector, wherein the element positions of the one or more classification vectors are occupied by scalar values representing the predetermined cardiac condition, and wherein the cardiac vector is aligned with a classification vector of the one or more classification vectors by adjusting each scalar value of the cardiac vector so one of the element positions of the cardiac vector equals a scalar value in a corresponding element position in a classification vector.
40. A system, comprising:
at least one catheter having at least a first cardiac electrode and a second cardiac electrode;
a sensing system attached to the first cardiac electrode and the second cardiac electrode, wherein the sensing system senses a first signal and a second signal representative of electrical cardiac activity;
a template generator circuit coupled to the sensing system, wherein the template generator circuit determines a first NSR representative complex and a second NSR representative complex from a plurality cardiac complexes sensed during normal sinus rhythm;
a morphology analyzer circuit coupled to the sensing system, where the morphology analyzer circuit locates a predetermined feature in a cardiac complex detected in the first signal and in the first NSR representative complex, wherein the predetermined feature includes a repeatably identifiable complex section common to the cardiac complex detected in the first signal and the first NSR representative complex; and
a signal feature comparison circuit coupled to the morphology analyzer circuit and the template generator circuit, where the signal feature comparison circuit aligns the predetermined feature in the cardiac complex monitored in the first signal with the predetermined feature on the first NSR representative complex and compares the cardiac complex monitored in the second signal to the second NSR representative complex to determine whether the cardiac complex is an arrhythmic complex.
41. The system of claim 40, where the morphology analyzer circuit locates the predetermined feature at a maximum deflection of the cardiac complex detected in the first signal and in the first NSR representative complex.
42. The method of claim 41, where the maximum deflection is along an R-wave sensed in the cardiac complex detected in the first signal and in the first NSR representative complex.
43. The system of claim 40, where the morphology analyzer circuit locates the predetermined feature at a beginning of the cardiac complex detected in the first signal and the first NSR representative complex as indicated by a predetermined deviation of the first signal from a baseline signal.
44. The system of claim 40, where the morphology analyzer circuit locates the predetermined feature at an ending of the cardiac complex detected in the first signal and the first NSR representative complex as indicated by a return of the first signal to a baseline signal for a predetermined time period.
45. The system of claim 40, where the sensing system includes a far-field sensing channel over which the first signal is monitored and a near-field sensing channel over which the second signal is monitored.
46. The system of claim 40, where the sensing system includes a near-field sensing channel over which the first signal is monitored and a far-field sensing channel over which the second signal is monitored.
47. The system of claim 40, where the second NSR representative complex has a second NSR morphology and the cardiac complex detected in the second signal has a second signal morphology, and the signal feature comparison circuit compares the second NSR morphology to the second signal morphology to determine whether the cardiac complex is an arrhythmic complex.
48. The system of claim 47, where the signal feature comparison circuit uses a correlation waveform analysis algorithm to compare the second NSR morphology to the second signal morphology.
49. The system of claim 40, where the sensing system senses at least a portion of a QRS-complex in the first signal and the second signal, the template generator circuit determines the first NSR representative complex and the second NSR representative complex from the at least a portion of the QRS-complexes sensed during normal sinus rhythm, and the signal feature comparison circuit compares the QRS-complex monitored in the second signal to the QRS-complex in the second NSR representative complex to determine whether the cardiac complex a ventricular tachycardia complex.
50. The system of claim 49, where the signal feature comparison circuit determines a percentage of ventricular tachycardia complexes for a plurality of cardiac complexes, and the control system applies therapy for treating a ventricular tachycardia when the percentage of ventricular tachycardia complexes exceeds a predetermined percentage threshold.
51. The system of claim 50, where the predetermined percentage threshold is 50 percent.
US09/848,605 1999-02-12 2001-05-03 System and method for a classifying cardiac complexes Expired - Fee Related US6438410B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US09/249,128 US6266554B1 (en) 1999-02-12 1999-02-12 System and method for classifying cardiac complexes
US09/848,605 US6438410B2 (en) 1999-02-12 2001-05-03 System and method for a classifying cardiac complexes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/848,605 US6438410B2 (en) 1999-02-12 2001-05-03 System and method for a classifying cardiac complexes
US10/219,730 US6728572B2 (en) 1999-02-12 2002-08-14 System and method for classifying cardiac complexes

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
US09249128 Continuation 1998-02-12
US09/249,128 Continuation US6266554B1 (en) 1999-02-12 1999-02-12 System and method for classifying cardiac complexes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/219,730 Continuation US6728572B2 (en) 1999-02-12 2002-08-14 System and method for classifying cardiac complexes

Publications (2)

Publication Number Publication Date
US20020019593A1 true US20020019593A1 (en) 2002-02-14
US6438410B2 US6438410B2 (en) 2002-08-20

Family

ID=22942162

Family Applications (3)

Application Number Title Priority Date Filing Date
US09/249,128 Expired - Lifetime US6266554B1 (en) 1999-02-12 1999-02-12 System and method for classifying cardiac complexes
US09/848,605 Expired - Fee Related US6438410B2 (en) 1999-02-12 2001-05-03 System and method for a classifying cardiac complexes
US10/219,730 Expired - Fee Related US6728572B2 (en) 1999-02-12 2002-08-14 System and method for classifying cardiac complexes

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/249,128 Expired - Lifetime US6266554B1 (en) 1999-02-12 1999-02-12 System and method for classifying cardiac complexes

Family Applications After (1)

Application Number Title Priority Date Filing Date
US10/219,730 Expired - Fee Related US6728572B2 (en) 1999-02-12 2002-08-14 System and method for classifying cardiac complexes

Country Status (3)

Country Link
US (3) US6266554B1 (en)
AU (1) AU3999800A (en)
WO (1) WO2000047278A1 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040088013A1 (en) * 2002-10-31 2004-05-06 Stadler Robert W. Detection of supraventricular tachycardia with 1:1 atrial to ventricular conduction
US20040111121A1 (en) * 2002-12-04 2004-06-10 Brown Mark L. Methods and apparatus for discriminating polymorphic tachyarrhythmias from monomorphic tachyarrhythmias facilitating detection of fibrillation
US20040111120A1 (en) * 2002-12-04 2004-06-10 Shantanu Sarkar Methods and apparatus for discriminating polymorphic tachyarrhythmias from monomorphic tachyarrhythmias facilitating detection of fibrillation
US20040111119A1 (en) * 2002-12-04 2004-06-10 Shantanu Sarkar Methods and apparatus for discriminating polymorphic tachyarrhythmias from monomorphic tachyarrhythmias facilitating detection of fibrillation
US20070016257A1 (en) * 2003-08-29 2007-01-18 Brown Mark L Methods and apparatus for discriminating polymorphic tachyarrhythmias from monomorphic tachyarrhythmias facilitating detection of fibrillation
US20080103401A1 (en) * 2006-10-31 2008-05-01 Mattias Rouw Form Parameter Forecaster for Analyzing Signals Distorted by Noise
US20080281369A1 (en) * 2007-05-08 2008-11-13 Kenknight Bruce System And Method For Determining The Origin Of A Sensed Beat
US20080281371A1 (en) * 2007-05-08 2008-11-13 Kenknight Bruce Method For Controlling Pacemaker Therapy
US20110071413A1 (en) * 2009-09-24 2011-03-24 Yi Zhang Morphology based ischemia detection using intracardiac electrograms
US20140142443A1 (en) * 2012-11-19 2014-05-22 Pacesetter, Inc. Systems and methods for exploiting pulmonary artery pressure obtained from an implantable sensor to detect cardiac rhythm irregularities

Families Citing this family (281)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5978707A (en) 1997-04-30 1999-11-02 Cardiac Pacemakers, Inc. Apparatus and method for treating ventricular tachyarrhythmias
US6112117A (en) * 1997-05-06 2000-08-29 Cardiac Pacemakers, Inc. Method and apparatus for treating cardiac arrhythmia using electrogram features
US6308095B1 (en) 1999-02-12 2001-10-23 Cardiac Pacemakers, Inc. System and method for arrhythmia discrimination
US6266554B1 (en) * 1999-02-12 2001-07-24 Cardiac Pacemakers, Inc. System and method for classifying cardiac complexes
US6223078B1 (en) 1999-03-12 2001-04-24 Cardiac Pacemakers, Inc. Discrimination of supraventricular tachycardia and ventricular tachycardia events
US6312388B1 (en) * 1999-03-12 2001-11-06 Cardiac Pacemakers, Inc. Method and system for verifying the integrity of normal sinus rhythm templates
US7181278B2 (en) 1999-05-21 2007-02-20 Cardiac Pacemakers, Inc. Apparatus and method for ventricular rate regularization
US7212860B2 (en) 1999-05-21 2007-05-01 Cardiac Pacemakers, Inc. Apparatus and method for pacing mode switching during atrial tachyarrhythmias
US8064997B2 (en) 1999-05-21 2011-11-22 Cardiac Pacemakers, Inc. Method and apparatus for treating irregular ventricular contractions such as during atrial arrhythmia
US6449503B1 (en) * 1999-07-14 2002-09-10 Cardiac Pacemakers, Inc. Classification of supraventricular and ventricular cardiac rhythms using cross channel timing algorithm
US6493579B1 (en) * 1999-08-20 2002-12-10 Cardiac Pacemakers, Inc. System and method for detection enhancement programming
US6400986B1 (en) * 2000-04-10 2002-06-04 Cardiac Pacemakers, Inc. Adaptive anti-tachycardia therapy apparatus and method
US6522925B1 (en) * 2000-05-13 2003-02-18 Cardiac Pacemakers, Inc. System and method for detection enhancement programming
US8512220B2 (en) 2000-05-26 2013-08-20 Cardiac Pacemakers, Inc. Rate smoothing control
US7039461B1 (en) * 2000-05-13 2006-05-02 Cardiac Pacemakers, Inc. Cardiac pacing system for prevention of ventricular fibrillation and ventricular tachycardia episode
US6701182B1 (en) * 2000-05-25 2004-03-02 Ge Medical Systems Information Technologies Gmbh Method and apparatus for analyzing a physiological waveform
US6424865B1 (en) 2000-07-13 2002-07-23 Cardiac Pacemakers, Inc. Ventricular conduction delay trending system and method
US6684100B1 (en) * 2000-10-31 2004-01-27 Cardiac Pacemakers, Inc. Curvature based method for selecting features from an electrophysiologic signals for purpose of complex identification and classification
US7369890B2 (en) * 2000-11-02 2008-05-06 Cardiac Pacemakers, Inc. Technique for discriminating between coordinated and uncoordinated cardiac rhythms
US6978177B1 (en) * 2000-11-14 2005-12-20 Cardiac Pacemakers, Inc. Method and apparatus for using atrial discrimination algorithms to determine optimal pacing therapy and therapy timing
US6754523B2 (en) * 2000-11-28 2004-06-22 J. Gerald Toole Method of analysis of the electrocardiogram
US7142918B2 (en) 2000-12-26 2006-11-28 Cardiac Pacemakers, Inc. Apparatus and method for pacing mode switching during atrial tachyarrhythmias
US6957100B2 (en) 2000-12-26 2005-10-18 Cardiac Pacemakers, Inc. Method and system for display of cardiac event intervals in a resynchronization pacemaker
DE10114724A1 (en) * 2001-03-21 2002-09-26 Biotronik Mess & Therapieg Device for characterizing the state of the myocardium using an excitation wave detector that measures the wave at two different points so that the myocardium state can be defined from a calculated difference of the two signals
US6622042B1 (en) * 2001-05-09 2003-09-16 Pacesetter, Inc. Implantable cardiac stimulation device and method utilizing electrogram spectral analysis for therapy administration
SE0101901D0 (en) * 2001-05-29 2001-05-29 St Jude Medical A cardiac stimulating device Comprising a morphology sensitive heart signal detector
US6526313B2 (en) * 2001-06-05 2003-02-25 Cardiac Pacemakers, Inc. System and method for classifying cardiac depolarization complexes with multi-dimensional correlation
US7340303B2 (en) * 2001-09-25 2008-03-04 Cardiac Pacemakers, Inc. Evoked response sensing for ischemia detection
US7286876B2 (en) * 2001-10-26 2007-10-23 Cardiac Pacemakers, Inc. Template-based capture verification for multi-site pacing
US7113823B2 (en) * 2001-10-26 2006-09-26 Cardiac Pacemakers, Inc. Morphology-based optimization of cardiac resynchronization therapy
US8509897B2 (en) * 2002-09-19 2013-08-13 Cardiac Pacemakers, Inc. Morphology-based diagnostic monitoring of electrograms by implantable cardiac device
US7392085B2 (en) * 2001-11-21 2008-06-24 Cameron Health, Inc. Multiple electrode vectors for implantable cardiac treatment devices
US7330757B2 (en) 2001-11-21 2008-02-12 Cameron Health, Inc. Method for discriminating between ventricular and supraventricular arrhythmias
US6950696B2 (en) * 2001-11-27 2005-09-27 St. Jude Medical Ab Method and circuit for detecting cardiac rhythm abnormalities by analyzing time differences between unipolar signals from a lead with a multi-electrode tip
US6909916B2 (en) * 2001-12-20 2005-06-21 Cardiac Pacemakers, Inc. Cardiac rhythm management system with arrhythmia classification and electrode selection
US6745075B2 (en) 2001-12-20 2004-06-01 St. Jude Medical Ab Method and apparatus for detection of premature atrial contraction
US7060030B2 (en) * 2002-01-08 2006-06-13 Cardiac Pacemakers, Inc. Two-hop telemetry interface for medical device
US6980861B1 (en) 2002-07-10 2005-12-27 Pacesetter, Inc. Implantable medical device and method for detecting cardiac events without using of refractory or blanking periods
US6925330B2 (en) * 2002-07-10 2005-08-02 Pacesetter, Inc. Implantable medical device and method for detecting cardiac events without using of refractory or blanking periods
US6950702B2 (en) * 2002-07-15 2005-09-27 Cardiac Pacemakers, Inc. Use of curvature based features for beat detection
US20040019287A1 (en) * 2002-07-26 2004-01-29 Harley White Similarity recovery post shock
US7844332B2 (en) 2002-10-18 2010-11-30 Cardiac Pacemakers, Inc. Atrioventricular delay adjustment enhancing ventricular tachyarrhythmia detection
US7031764B2 (en) * 2002-11-08 2006-04-18 Cardiac Pacemakers, Inc. Cardiac rhythm management systems and methods using multiple morphology templates for discriminating between rhythms
US7072711B2 (en) 2002-11-12 2006-07-04 Cardiac Pacemakers, Inc. Implantable device for delivering cardiac drug therapy
US7031770B2 (en) * 2002-12-31 2006-04-18 Cardiac Pacemakers, Inc. Distinguishing sinus tachycardia from atrial fibrillation and atrial flutter through analysis of atrial channel wavelet transforms
US7392081B2 (en) * 2003-02-28 2008-06-24 Cardiac Pacemakers, Inc. Subcutaneous cardiac stimulator employing post-shock transthoracic asystole prevention pacing
US7328066B1 (en) * 2003-03-28 2008-02-05 Pacesetter, Inc. Implantable cardiac stimulation device, system and method that identifies and prevents impending arrhythmias of the atria
US20040220626A1 (en) * 2003-04-11 2004-11-04 Wagner Darrell Orvin Distributed subcutaneous defibrillation system
US20050107838A1 (en) * 2003-09-18 2005-05-19 Lovett Eric G. Subcutaneous cardiac rhythm management with disordered breathing detection and treatment
US7529592B2 (en) * 2003-04-11 2009-05-05 Cardiac Pacemakers, Inc. Subcutaneous electrode and lead with temporary pharmacological agents
US20040220628A1 (en) * 2003-04-11 2004-11-04 Wagner Darrell Orvin Subcutaneous defibrillation timing correlated with induced skeletal muscle contraction
US7566318B2 (en) 2003-04-11 2009-07-28 Cardiac Pacemakers, Inc. Ultrasonic subcutaneous dissection tool incorporating fluid delivery
US7218966B2 (en) 2003-04-11 2007-05-15 Cardiac Pacemakers, Inc. Multi-parameter arrhythmia discrimination
US7499758B2 (en) * 2003-04-11 2009-03-03 Cardiac Pacemakers, Inc. Helical fixation elements for subcutaneous electrodes
US7555335B2 (en) 2003-04-11 2009-06-30 Cardiac Pacemakers, Inc. Biopotential signal source separation using source impedances
US7236819B2 (en) 2003-04-11 2007-06-26 Cardiac Pacemakers, Inc. Separation of a subcutaneous cardiac signal from a plurality of composite signals
US20040230229A1 (en) * 2003-04-11 2004-11-18 Lovett Eric G. Hybrid transthoracic/intrathoracic cardiac stimulation devices and methods
US7389138B2 (en) * 2003-04-11 2008-06-17 Cardiac Pacemakers, Inc. Electrode placement determination for subcutaneous cardiac monitoring and therapy
US7493175B2 (en) * 2003-04-11 2009-02-17 Cardiac Pacemakers, Inc. Subcutaneous lead with tined fixation
US7117035B2 (en) 2003-04-11 2006-10-03 Cardiac Pacemakers, Inc. Subcutaneous cardiac stimulation system with patient activity sensing
US7047071B2 (en) 2003-04-11 2006-05-16 Cardiac Pacemakers, Inc. Patient stratification for implantable subcutaneous cardiac monitoring and therapy
US8116868B2 (en) 2003-04-11 2012-02-14 Cardiac Pacemakers, Inc. Implantable device with cardiac event audio playback
US7865233B2 (en) 2003-04-11 2011-01-04 Cardiac Pacemakers, Inc. Subcutaneous cardiac signal discrimination employing non-electrophysiologic signal
US20040230272A1 (en) * 2003-04-11 2004-11-18 Cates Adam W. Subcutaneous lead with temporary pharmacological agents
US7349742B2 (en) * 2003-04-11 2008-03-25 Cardiac Pacemakers, Inc. Expandable fixation elements for subcutaneous electrodes
US20040204734A1 (en) * 2003-04-11 2004-10-14 Wagner Darrell Orvin Tunneling tool with subcutaneous transdermal illumination
US7302294B2 (en) 2003-04-11 2007-11-27 Cardiac Pacemakers, Inc. Subcutaneous cardiac sensing and stimulation system employing blood sensor
US7979122B2 (en) 2003-04-11 2011-07-12 Cardiac Pacemakers, Inc. Implantable sudden cardiac death prevention device with reduced programmable feature set
US7702399B2 (en) * 2003-04-11 2010-04-20 Cardiac Pacemakers, Inc. Subcutaneous electrode and lead with phoresis based pharmacological agent delivery
WO2004093699A1 (en) * 2003-04-22 2004-11-04 Patrick Leahy A device for use in surgery
US7734346B2 (en) * 2003-04-25 2010-06-08 Medtronic, Inc. Identification of premature atrial contractions that trigger arrhythmia
US7167747B2 (en) * 2003-05-13 2007-01-23 Medtronic, Inc. Identification of oversensing using sinus R-wave template
US7477932B2 (en) 2003-05-28 2009-01-13 Cardiac Pacemakers, Inc. Cardiac waveform template creation, maintenance and use
US7248921B2 (en) * 2003-06-02 2007-07-24 Cameron Health, Inc. Method and devices for performing cardiac waveform appraisal
US7792571B2 (en) * 2003-06-27 2010-09-07 Cardiac Pacemakers, Inc. Tachyarrhythmia detection and discrimination based on curvature parameters
US7500955B2 (en) * 2003-06-27 2009-03-10 Cardiac Pacemaker, Inc. Signal compression based on curvature parameters
US8192376B2 (en) 2003-08-18 2012-06-05 Cardiac Pacemakers, Inc. Sleep state classification
EP2008581B1 (en) 2003-08-18 2011-08-17 Cardiac Pacemakers, Inc. Patient monitoring, diagnosis, and/or therapy systems and methods
US7720541B2 (en) 2003-08-18 2010-05-18 Cardiac Pacemakers, Inc. Adaptive therapy for disordered breathing
US7396333B2 (en) 2003-08-18 2008-07-08 Cardiac Pacemakers, Inc. Prediction of disordered breathing
US7320675B2 (en) 2003-08-21 2008-01-22 Cardiac Pacemakers, Inc. Method and apparatus for modulating cellular metabolism during post-ischemia or heart failure
US7469697B2 (en) * 2003-09-18 2008-12-30 Cardiac Pacemakers, Inc. Feedback system and method for sleep disordered breathing therapy
US7591265B2 (en) 2003-09-18 2009-09-22 Cardiac Pacemakers, Inc. Coordinated use of respiratory and cardiac therapies for sleep disordered breathing
US7678061B2 (en) * 2003-09-18 2010-03-16 Cardiac Pacemakers, Inc. System and method for characterizing patient respiration
US7662101B2 (en) 2003-09-18 2010-02-16 Cardiac Pacemakers, Inc. Therapy control based on cardiopulmonary status
US7887493B2 (en) 2003-09-18 2011-02-15 Cardiac Pacemakers, Inc. Implantable device employing movement sensing for detecting sleep-related disorders
US7757690B2 (en) 2003-09-18 2010-07-20 Cardiac Pacemakers, Inc. System and method for moderating a therapy delivered during sleep using physiologic data acquired during non-sleep
US8251061B2 (en) 2003-09-18 2012-08-28 Cardiac Pacemakers, Inc. Methods and systems for control of gas therapy
US7510531B2 (en) 2003-09-18 2009-03-31 Cardiac Pacemakers, Inc. System and method for discrimination of central and obstructive disordered breathing events
US20050080348A1 (en) 2003-09-18 2005-04-14 Stahmann Jeffrey E. Medical event logbook system and method
US8606356B2 (en) * 2003-09-18 2013-12-10 Cardiac Pacemakers, Inc. Autonomic arousal detection system and method
US7668591B2 (en) 2003-09-18 2010-02-23 Cardiac Pacemakers, Inc. Automatic activation of medical processes
US7572225B2 (en) * 2003-09-18 2009-08-11 Cardiac Pacemakers, Inc. Sleep logbook
US7302295B2 (en) 2003-09-18 2007-11-27 Cardiac Pacemakers, Inc. Method and apparatus for mimicking respiratory sinus arrhythmia with cardiac pacing controlled via external respiration therapy device
US7468040B2 (en) * 2003-09-18 2008-12-23 Cardiac Pacemakers, Inc. Methods and systems for implantably monitoring external breathing therapy
US8027722B1 (en) 2003-10-17 2011-09-27 Pacesetter, Inc. Multifocal PVC detection for prevention of arrhythmias
EP1691683B1 (en) 2003-11-26 2014-12-31 CardioNet, Inc. System and method for processing and presenting arrhythmia information to facilitate heart arrhythmia identification and treatment
US7319900B2 (en) 2003-12-11 2008-01-15 Cardiac Pacemakers, Inc. Cardiac response classification using multiple classification windows
US8521284B2 (en) 2003-12-12 2013-08-27 Cardiac Pacemakers, Inc. Cardiac response classification using multisite sensing and pacing
US7774064B2 (en) 2003-12-12 2010-08-10 Cardiac Pacemakers, Inc. Cardiac response classification using retriggerable classification windows
US7412287B2 (en) * 2003-12-22 2008-08-12 Cardiac Pacemakers, Inc. Automatic sensing vector selection for morphology-based capture verification
US20050226421A1 (en) * 2004-02-18 2005-10-13 Interdigital Technology Corporation Method and system for using watermarks in communication systems
US20050215884A1 (en) * 2004-02-27 2005-09-29 Greicius Michael D Evaluation of Alzheimer's disease using an independent component analysis of an individual's resting-state functional MRI
US7174205B2 (en) * 2004-04-05 2007-02-06 Hewlett-Packard Development Company, L.P. Cardiac diagnostic system and method
KR100601953B1 (en) * 2004-05-03 2006-07-14 삼성전자주식회사 Capacitor of memory device and fabrication method thereof
US7515956B2 (en) * 2004-05-12 2009-04-07 Cardiac Pacemakers, Inc. Template based AV/VA interval comparison for the discrimination of cardiac arrhythmias
US7747323B2 (en) 2004-06-08 2010-06-29 Cardiac Pacemakers, Inc. Adaptive baroreflex stimulation therapy for disordered breathing
US7706866B2 (en) 2004-06-24 2010-04-27 Cardiac Pacemakers, Inc. Automatic orientation determination for ECG measurements using multiple electrodes
US7228176B2 (en) * 2004-07-22 2007-06-05 Cardiac Pacemakers, Inc. Systems, devices, and methods for tachyarrhythmia discrimination or therapy decisions
US7277756B2 (en) * 2004-08-16 2007-10-02 Cardiac Pacemakers, Inc. Risk of death indicator
DE102004043005A1 (en) * 2004-09-02 2006-03-09 Biotronik Vi Patent Ag Signal processing device for physiological signals
US7894893B2 (en) * 2004-09-30 2011-02-22 Cardiac Pacemakers, Inc. Arrhythmia classification and therapy selection
US7890159B2 (en) 2004-09-30 2011-02-15 Cardiac Pacemakers, Inc. Cardiac activation sequence monitoring and tracking
US7647108B2 (en) * 2004-09-30 2010-01-12 Cardiac Pacemakers, Inc. Methods and systems for selection of cardiac pacing electrode configurations
US7996073B2 (en) * 2004-10-13 2011-08-09 International Business Machines Corporation System and method for interpreting electrocardiograms
US7212849B2 (en) 2004-10-28 2007-05-01 Cardiac Pacemakers, Inc. Methods and apparatuses for arrhythmia detection and classification using wireless ECG
US7277747B2 (en) * 2004-11-23 2007-10-02 Cardiac Pacemakers, Inc. Arrhythmia memory for tachyarrhythmia discrimination
US7933651B2 (en) * 2004-11-23 2011-04-26 Cardiac Pacemakers, Inc. Cardiac template generation based on patient response information
US7228173B2 (en) * 2004-11-23 2007-06-05 Cardiac Pacemakers, Inc. Cardiac tachyarrhythmia therapy selection based on patient response information
US7477935B2 (en) * 2004-11-29 2009-01-13 Cameron Health, Inc. Method and apparatus for beat alignment and comparison
US7376458B2 (en) 2004-11-29 2008-05-20 Cameron Health, Inc. Method for defining signal templates in implantable cardiac devices
US7797036B2 (en) 2004-11-30 2010-09-14 Cardiac Pacemakers, Inc. Cardiac activation sequence monitoring for ischemia detection
US7328063B2 (en) 2004-11-30 2008-02-05 Cardiac Pacemakers, Inc. Method and apparatus for arrhythmia classification using atrial signal mapping
US7333855B2 (en) * 2004-12-01 2008-02-19 Medtronic, Inc. Method and apparatus for determining oversensing in a medical device
US8818504B2 (en) 2004-12-16 2014-08-26 Cardiac Pacemakers Inc Leadless cardiac stimulation device employing distributed logic
US7981065B2 (en) 2004-12-20 2011-07-19 Cardiac Pacemakers, Inc. Lead electrode incorporating extracellular matrix
US8060219B2 (en) 2004-12-20 2011-11-15 Cardiac Pacemakers, Inc. Epicardial patch including isolated extracellular matrix with pacing electrodes
US7996072B2 (en) * 2004-12-21 2011-08-09 Cardiac Pacemakers, Inc. Positionally adaptable implantable cardiac device
JP2006185060A (en) * 2004-12-27 2006-07-13 Fujitsu Ltd Method for inputting password
US7430446B2 (en) * 2005-01-20 2008-09-30 Cardiac Pacemakers, Inc. Methods and apparatuses for cardiac arrhythmia classification using morphology stability
US8160697B2 (en) 2005-01-25 2012-04-17 Cameron Health, Inc. Method for adapting charge initiation for an implantable cardioverter-defibrillator
US7680534B2 (en) * 2005-02-28 2010-03-16 Cardiac Pacemakers, Inc. Implantable cardiac device with dyspnea measurement
US7818056B2 (en) 2005-03-24 2010-10-19 Cardiac Pacemakers, Inc. Blending cardiac rhythm detection processes
US7555340B2 (en) 2005-04-01 2009-06-30 Cardiac Pacemakers, Inc. Electrogram morphology-based CRT optimization
US7623914B1 (en) * 2005-04-11 2009-11-24 Pacesetter, Inc. Reconfigurable digital network for processing data in an implantable medical device
US7630763B2 (en) 2005-04-20 2009-12-08 Cardiac Pacemakers, Inc. Thoracic or intracardiac impedance detection with automatic vector selection
US7392086B2 (en) 2005-04-26 2008-06-24 Cardiac Pacemakers, Inc. Implantable cardiac device and method for reduced phrenic nerve stimulation
US20060247693A1 (en) 2005-04-28 2006-11-02 Yanting Dong Non-captured intrinsic discrimination in cardiac pacing response classification
US7917196B2 (en) 2005-05-09 2011-03-29 Cardiac Pacemakers, Inc. Arrhythmia discrimination using electrocardiograms sensed from multiple implanted electrodes
US7805185B2 (en) 2005-05-09 2010-09-28 Cardiac Pacemakers, In. Posture monitoring using cardiac activation sequences
US7457664B2 (en) 2005-05-09 2008-11-25 Cardiac Pacemakers, Inc. Closed loop cardiac resynchronization therapy using cardiac activation sequence information
US7509170B2 (en) 2005-05-09 2009-03-24 Cardiac Pacemakers, Inc. Automatic capture verification using electrocardiograms sensed from multiple implanted electrodes
US8391990B2 (en) 2005-05-18 2013-03-05 Cardiac Pacemakers, Inc. Modular antitachyarrhythmia therapy system
US20060271121A1 (en) 2005-05-25 2006-11-30 Cardiac Pacemakers, Inc. Closed loop impedance-based cardiac resynchronization therapy systems, devices, and methods
US7310551B1 (en) * 2005-06-02 2007-12-18 Pacesetter, Inc. Diagnostic gauge for cardiac health analysis
US9314210B2 (en) * 2005-06-13 2016-04-19 Cardiac Pacemakers, Inc. Method and apparatus for rate-dependent morphology-based cardiac arrhythmia classification
US8116867B2 (en) 2005-08-04 2012-02-14 Cameron Health, Inc. Methods and devices for tachyarrhythmia sensing and high-pass filter bypass
US9839781B2 (en) 2005-08-22 2017-12-12 Cardiac Pacemakers, Inc. Intracardiac impedance and its applications
US8494618B2 (en) * 2005-08-22 2013-07-23 Cardiac Pacemakers, Inc. Intracardiac impedance and its applications
US7908001B2 (en) * 2005-08-23 2011-03-15 Cardiac Pacemakers, Inc. Automatic multi-level therapy based on morphologic organization of an arrhythmia
US20070049975A1 (en) * 2005-09-01 2007-03-01 Cates Adam W Active can with dedicated defibrillation and sensing electrodes
US7775983B2 (en) * 2005-09-16 2010-08-17 Cardiac Pacemakers, Inc. Rapid shallow breathing detection for use in congestive heart failure status determination
US7751876B2 (en) * 2005-09-23 2010-07-06 Hewlett-Packard Development Company, L.P. Method and system for detecting premature ventricular contraction from a surface electrocardiogram
EP2471448A1 (en) 2005-10-14 2012-07-04 Nanostim, Inc. Leadless cardiac pacemaker and system
US9168383B2 (en) 2005-10-14 2015-10-27 Pacesetter, Inc. Leadless cardiac pacemaker with conducted communication
US8046060B2 (en) * 2005-11-14 2011-10-25 Cardiac Pacemakers, Inc. Differentiating arrhythmic events having different origins
US20070118180A1 (en) 2005-11-18 2007-05-24 Quan Ni Cardiac resynchronization therapy for improved hemodynamics based on disordered breathing detection
US7766840B2 (en) 2005-12-01 2010-08-03 Cardiac Pacemakers, Inc. Method and system for heart failure status evaluation based on a disordered breathing index
US7662105B2 (en) 2005-12-14 2010-02-16 Cardiac Pacemakers, Inc. Systems and methods for determining respiration metrics
US7761158B2 (en) * 2005-12-20 2010-07-20 Cardiac Pacemakers, Inc. Detection of heart failure decompensation based on cumulative changes in sensor signals
US7653431B2 (en) * 2005-12-20 2010-01-26 Cardiac Pacemakers, Inc. Arrhythmia discrimination based on determination of rate dependency
US8532762B2 (en) * 2005-12-20 2013-09-10 Cardiac Pacemakers, Inc. Discriminating polymorphic and monomorphic cardiac rhythms using template generation
US7582061B2 (en) * 2005-12-22 2009-09-01 Cardiac Pacemakers, Inc. Method and apparatus for morphology-based arrhythmia classification using cardiac and other physiological signals
WO2007106781A2 (en) * 2006-03-10 2007-09-20 University Of Rochester Ecg-based differentiation of lqt1 and lqt2 mutation
US7769452B2 (en) * 2006-03-29 2010-08-03 Medtronic, Inc. Method and apparatus for detecting arrhythmias in a medical device
US7819816B2 (en) * 2006-03-29 2010-10-26 Cardiac Pacemakers, Inc. Periodic disordered breathing detection
US7610086B1 (en) * 2006-03-31 2009-10-27 Pacesetter, Inc. System and method for detecting cardiac ischemia in real-time using a pattern classifier implemented within an implanted medical device
US8155734B2 (en) * 2006-04-19 2012-04-10 Cardiac Pacemakers, Inc. Probabilistic fusion in arrhythmia diagnosis and therapy
US7623909B2 (en) * 2006-05-26 2009-11-24 Cameron Health, Inc. Implantable medical devices and programmers adapted for sensing vector selection
US20070276452A1 (en) * 2006-05-26 2007-11-29 Cameron Health, Inc. Implantable medical device systems having initialization functions and methods of operation
US8788023B2 (en) 2006-05-26 2014-07-22 Cameron Health, Inc. Systems and methods for sensing vector selection in an implantable medical device
US8527048B2 (en) 2006-06-29 2013-09-03 Cardiac Pacemakers, Inc. Local and non-local sensing for cardiac pacing
US7580741B2 (en) * 2006-08-18 2009-08-25 Cardiac Pacemakers, Inc. Method and device for determination of arrhythmia rate zone thresholds using a probability function
US7738950B2 (en) * 2006-09-13 2010-06-15 Cardiac Pacemakers, Inc. Method and apparatus for identifying potentially misclassified arrhythmic episodes
US8712507B2 (en) * 2006-09-14 2014-04-29 Cardiac Pacemakers, Inc. Systems and methods for arranging and labeling cardiac episodes
US8948867B2 (en) 2006-09-14 2015-02-03 Cardiac Pacemakers, Inc. Capture detection with cross chamber backup pacing
US8209013B2 (en) 2006-09-14 2012-06-26 Cardiac Pacemakers, Inc. Therapeutic electrical stimulation that avoids undesirable activation
US8014851B2 (en) 2006-09-26 2011-09-06 Cameron Health, Inc. Signal analysis in implantable cardiac treatment devices
US7941208B2 (en) 2006-11-29 2011-05-10 Cardiac Pacemakers, Inc. Therapy delivery for identified tachyarrhythmia episode types
US7765002B2 (en) * 2006-12-08 2010-07-27 Cardiac Pacemakers, Inc. Rate aberrant beat selection and template formation
US7783340B2 (en) 2007-01-16 2010-08-24 Cameron Health, Inc. Systems and methods for sensing vector selection in an implantable medical device using a polynomial approach
US8200341B2 (en) 2007-02-07 2012-06-12 Cameron Health, Inc. Sensing vector selection in a cardiac stimulus device with postural assessment
US8052611B2 (en) 2007-03-14 2011-11-08 Cardiac Pacemakers, Inc. Method and apparatus for management of heart failure hospitalization
US8265736B2 (en) 2007-08-07 2012-09-11 Cardiac Pacemakers, Inc. Method and apparatus to perform electrode combination selection
US9037239B2 (en) 2007-08-07 2015-05-19 Cardiac Pacemakers, Inc. Method and apparatus to perform electrode combination selection
US8591430B2 (en) 2007-09-14 2013-11-26 Corventis, Inc. Adherent device for respiratory monitoring
US9411936B2 (en) 2007-09-14 2016-08-09 Medtronic Monitoring, Inc. Dynamic pairing of patients to data collection gateways
US8116841B2 (en) 2007-09-14 2012-02-14 Corventis, Inc. Adherent device with multiple physiological sensors
EP2194864B1 (en) 2007-09-14 2018-08-29 Medtronic Monitoring, Inc. System and methods for wireless body fluid monitoring
EP2194858B1 (en) 2007-09-14 2017-11-22 Corventis, Inc. Medical device automatic start-up upon contact to patient tissue
WO2009036256A1 (en) 2007-09-14 2009-03-19 Corventis, Inc. Injectable physiological monitoring system
EP2194856A4 (en) 2007-09-14 2014-07-16 Corventis Inc Adherent cardiac monitor with advanced sensing capabilities
US20090149904A1 (en) 2007-12-11 2009-06-11 Cardiac Pacemakers, Inc. Lv unipolar sensing or pacing vector
WO2009092055A1 (en) 2008-01-18 2009-07-23 Cameron Health, Inc. Data manipulation following delivery of a cardiac stimulus in an implantable cardiac stimulus device
WO2009094335A1 (en) 2008-01-22 2009-07-30 Cardiac Pacemakers, Inc. Respiration as a trigger for therapy optimization
EP2254661B1 (en) 2008-02-14 2015-10-07 Cardiac Pacemakers, Inc. Apparatus for phrenic stimulation detection
EP2268358B1 (en) 2008-03-07 2013-05-22 Cameron Health, Inc. Accurate cardiac event detection in an implantable cardiac stimulus device
EP2574372B8 (en) 2008-03-07 2014-10-15 Cameron Health, Inc. Devices for accurately classifying cardiac activity
US8160687B2 (en) 2008-05-07 2012-04-17 Cameron Health, Inc. Methods and devices for accurately classifying cardiac activity
WO2009114548A1 (en) 2008-03-12 2009-09-17 Corventis, Inc. Heart failure decompensation prediction based on cardiac rhythm
WO2009146214A1 (en) 2008-04-18 2009-12-03 Corventis, Inc. Method and apparatus to measure bioelectric impedance of patient tissue
US7783342B2 (en) * 2008-04-21 2010-08-24 International Business Machines Corporation System and method for inferring disease similarity by shape matching of ECG time series
EP2320999A1 (en) * 2008-06-02 2011-05-18 Medtronic, Inc. Sensing integrity determination based on cardiovascular pressure
WO2009148425A1 (en) * 2008-06-02 2009-12-10 Medtronic, Inc. Impedance variability analysis to identify lead-related conditions
US9037240B2 (en) * 2008-06-02 2015-05-19 Medtronic, Inc. Electrode lead integrity reports
US20090299421A1 (en) * 2008-06-02 2009-12-03 Medtronic, Inc. Evaluation of implantable medical device sensing integrity based on evoked signals
EP2303403B1 (en) * 2008-06-02 2016-09-14 Medtronic, Inc. Electrogram storage for suspected non-physiological episodes
US7974690B2 (en) * 2008-06-30 2011-07-05 Medtronic, Inc. Lead integrity testing during suspected tachyarrhythmias
US9522277B2 (en) 2008-07-28 2016-12-20 Medtronic, Inc. Lead integrity testing triggered by sensed signal saturation
US7953488B2 (en) * 2008-07-31 2011-05-31 Medtronic, Inc. Pre-qualification of an alternate sensing configuration
US8078277B2 (en) * 2008-10-29 2011-12-13 Medtronic, Inc. Identification and remediation of oversensed cardiac events using far-field electrograms
US10118042B2 (en) 2008-10-31 2018-11-06 Medtronic, Inc. Lead integrity testing triggered by sensed asystole
WO2010068933A1 (en) 2008-12-12 2010-06-17 Cameron Health, Inc. Electrode spacing in a subcutaneous implantable cardiac stimulus device
US8527068B2 (en) 2009-02-02 2013-09-03 Nanostim, Inc. Leadless cardiac pacemaker with secondary fixation capability
JP5702375B2 (en) 2009-06-29 2015-04-15 キャメロン ヘルス、 インコーポレイテッド Adaptive check treatable arrhythmias in implantable cardiac therapy device
US8483808B2 (en) 2009-09-25 2013-07-09 Yanting Dong Methods and systems for characterizing cardiac signal morphology using K-fit analysis
WO2011050283A2 (en) 2009-10-22 2011-04-28 Corventis, Inc. Remote detection and monitoring of functional chronotropic incompetence
US8265737B2 (en) 2009-10-27 2012-09-11 Cameron Health, Inc. Methods and devices for identifying overdetection of cardiac signals
US8744555B2 (en) 2009-10-27 2014-06-03 Cameron Health, Inc. Adaptive waveform appraisal in an implantable cardiac system
US9451897B2 (en) 2009-12-14 2016-09-27 Medtronic Monitoring, Inc. Body adherent patch with electronics for physiologic monitoring
JP5951504B2 (en) 2010-01-18 2016-07-13 エルミンダ エルティーディー.Elminda Ltd. Methods and systems for weighted neurophysiological data analysis
US8548573B2 (en) 2010-01-18 2013-10-01 Cameron Health, Inc. Dynamically filtered beat detection in an implantable cardiac device
US8396543B2 (en) * 2010-01-28 2013-03-12 Medtronic, Inc. Storage of data for evaluation of lead integrity
US8903490B2 (en) * 2010-03-03 2014-12-02 Cardiac Pacemakers, Inc. Methods and systems for recognizing arrhythmias using neural stimulation
US8965498B2 (en) 2010-04-05 2015-02-24 Corventis, Inc. Method and apparatus for personalized physiologic parameters
US8483813B2 (en) 2010-06-30 2013-07-09 Medtronic, Inc. System and method for establishing episode profiles of detected tachycardia episodes
US9060692B2 (en) 2010-10-12 2015-06-23 Pacesetter, Inc. Temperature sensor for a leadless cardiac pacemaker
CN103249452A (en) 2010-10-12 2013-08-14 内诺斯蒂姆股份有限公司 Temperature sensor for a leadless cardiac pacemaker
CN103249454A (en) 2010-10-13 2013-08-14 内诺斯蒂姆股份有限公司 Leadless cardiac pacemaker with anti-nscrewing feature
US8615310B2 (en) 2010-12-13 2013-12-24 Pacesetter, Inc. Delivery catheter systems and methods
EP3090779B1 (en) 2010-12-13 2017-11-08 Pacesetter, Inc. Pacemaker retrieval systems
CN103328040B (en) 2010-12-20 2016-09-14 内诺斯蒂姆股份有限公司 No pacemaker having radial wire securing mechanism
US8521268B2 (en) * 2011-05-10 2013-08-27 Medtronic, Inc. Techniques for determining cardiac cycle morphology
US9020596B2 (en) 2011-07-15 2015-04-28 Cardiac Pacemakers, Inc. Management of fusion beat detection during capture threshold determination
CN103917159B (en) 2011-07-20 2017-02-15 艾欧敏达有限公司 A method for estimating a concussion and systems
WO2013032760A1 (en) 2011-08-29 2013-03-07 Cardiac Pacemakers, Inc. Algorithm for narrative generation
US8774909B2 (en) 2011-09-26 2014-07-08 Medtronic, Inc. Episode classifier algorithm
US8437840B2 (en) 2011-09-26 2013-05-07 Medtronic, Inc. Episode classifier algorithm
US8744560B2 (en) 2011-09-30 2014-06-03 Medtronic, Inc. Electrogram summary
US9668668B2 (en) 2011-09-30 2017-06-06 Medtronic, Inc. Electrogram summary
US8886296B2 (en) 2011-10-14 2014-11-11 Medtronic, Inc. T-wave oversensing
US8521281B2 (en) 2011-10-14 2013-08-27 Medtronic, Inc. Electrogram classification algorithm
US9511236B2 (en) 2011-11-04 2016-12-06 Pacesetter, Inc. Leadless cardiac pacemaker with integral battery and redundant welds
CN104717918B (en) * 2012-06-20 2017-07-04 波士顿科学医学有限公司 During electrophysiological mapping enhanced signal vector analysis to inhibit activated globally
US10016145B2 (en) 2012-06-20 2018-07-10 Boston Scientific Scimed, Inc. Far-field vs local activation discrimination on multi-electrode EGMS using vector analysis in multi-dimensional signal space
EP2879758B1 (en) 2012-08-01 2018-04-18 Pacesetter, Inc. Biostimulator circuit with flying cell
US9681817B2 (en) 2012-12-20 2017-06-20 Boston Scientific Scimed, Inc. Suppression of global activation signals during anatomical mapping
US9439578B2 (en) 2012-12-27 2016-09-13 Boston Scientific Scimed, Inc. Artifact cancellation to suppress far-field activation during electrophysiology mapping
EP2967404B1 (en) 2013-03-11 2019-05-22 Cameron Health, Inc. Device implementing dual criteria for arrhythmia detection
US9579065B2 (en) 2013-03-12 2017-02-28 Cameron Health Inc. Cardiac signal vector selection with monophasic and biphasic shape consideration
US8825145B1 (en) * 2013-03-14 2014-09-02 Medtronic, Inc. Beat-morphology matching scheme for cardiac sensing and event detection
EP3030143A1 (en) 2013-08-05 2016-06-15 Cardiac Pacemakers, Inc. System and method for detecting worsening of heart failure based on rapid shallow breathing index
WO2015106015A1 (en) 2014-01-10 2015-07-16 Cardiac Pacemakers, Inc. Systems and methods for detecting cardiac arrhythmias
US9526908B2 (en) 2014-04-01 2016-12-27 Medtronic, Inc. Method and apparatus for discriminating tachycardia events in a medical device
US9808640B2 (en) 2014-04-10 2017-11-07 Medtronic, Inc. Method and apparatus for discriminating tachycardia events in a medical device using two sensing vectors
US9352165B2 (en) 2014-04-17 2016-05-31 Medtronic, Inc. Method and apparatus for verifying discriminating of tachycardia events in a medical device having dual sensing vectors
US9795312B2 (en) 2014-04-24 2017-10-24 Medtronic, Inc. Method and apparatus for adjusting a blanking period for selecting a sensing vector configuration in a medical device
US10278601B2 (en) 2014-04-24 2019-05-07 Medtronic, Inc. Method and apparatus for selecting a sensing vector configuration in a medical device
US10252067B2 (en) 2014-04-24 2019-04-09 Medtronic, Inc. Method and apparatus for adjusting a blanking period during transitioning between operating states in a medical device
US10244957B2 (en) 2014-04-24 2019-04-02 Medtronic, Inc. Method and apparatus for selecting a sensing vector configuration in a medical device
JP6375446B2 (en) 2014-06-03 2018-08-15 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Medical device for the mapping of the heart tissue
US9610025B2 (en) 2014-07-01 2017-04-04 Medtronic, Inc. Method and apparatus for verifying discriminating of tachycardia events in a medical device having dual sensing vectors
US9554714B2 (en) 2014-08-14 2017-01-31 Cameron Health Inc. Use of detection profiles in an implantable medical device
WO2016033197A2 (en) 2014-08-28 2016-03-03 Cardiac Pacemakers, Inc. Medical device with triggered blanking period
WO2016034203A1 (en) * 2014-09-01 2016-03-10 Schiller Ag Method and device for automatically classifying heartbeats, computer program product and ecg device for carrying out the method
WO2016126968A1 (en) 2015-02-06 2016-08-11 Cardiac Pacemakers, Inc. Systems and methods for safe delivery of electrical stimulation therapy
EP3253450A1 (en) 2015-02-06 2017-12-13 Cardiac Pacemakers, Inc. Systems and methods for treating cardiac arrhythmias
WO2016130477A2 (en) 2015-02-09 2016-08-18 Cardiac Pacemakers, Inc. Implantable medical device with radiopaque id tag
CN107427222A (en) 2015-03-18 2017-12-01 心脏起搏器股份公司 Communications in a medical device system with link quality assessment
US10050700B2 (en) 2015-03-18 2018-08-14 Cardiac Pacemakers, Inc. Communications in a medical device system with temporal optimization
EP3337558A1 (en) 2015-08-20 2018-06-27 Cardiac Pacemakers, Inc. Systems and methods for communication between medical devices
US9956414B2 (en) 2015-08-27 2018-05-01 Cardiac Pacemakers, Inc. Temporal configuration of a motion sensor in an implantable medical device
US9968787B2 (en) 2015-08-27 2018-05-15 Cardiac Pacemakers, Inc. Spatial configuration of a motion sensor in an implantable medical device
US10226631B2 (en) 2015-08-28 2019-03-12 Cardiac Pacemakers, Inc. Systems and methods for infarct detection
CN108136189A (en) 2015-08-28 2018-06-08 心脏起搏器股份公司 Systems and methods for behaviorally responsive signal detection and therapy delivery
WO2017040115A1 (en) 2015-08-28 2017-03-09 Cardiac Pacemakers, Inc. System for detecting tamponade
US10092760B2 (en) 2015-09-11 2018-10-09 Cardiac Pacemakers, Inc. Arrhythmia detection and confirmation
US10065041B2 (en) 2015-10-08 2018-09-04 Cardiac Pacemakers, Inc. Devices and methods for adjusting pacing rates in an implantable medical device
US20170112399A1 (en) 2015-10-23 2017-04-27 Cardiac Pacemakers, Inc. Multi-vector sensing in cardiac devices using a hybrid approach
WO2017106693A1 (en) 2015-12-17 2017-06-22 Cardiac Pacemakers, Inc. Conducted communication in a medical device system
US10029107B1 (en) 2017-01-26 2018-07-24 Cardiac Pacemakers, Inc. Leadless device with overmolded components

Family Cites Families (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4336810A (en) 1980-09-30 1982-06-29 Del Mar Avionics Method and apparatus for arrhythmia analysis of ECG recordings
WO1983003744A1 (en) 1982-04-23 1983-11-10 Reinhold Herbert Edward Jr Ambulatory monitoring system with real time analysis and telephone transmission
US4583553A (en) 1983-11-15 1986-04-22 Medicomp, Inc. Ambulatory ECG analyzer and recorder
US4721114A (en) 1986-02-21 1988-01-26 Cardiac Pacemakers, Inc. Method of detecting P-waves in ECG recordings
US4838278A (en) 1987-02-26 1989-06-13 Hewlett-Packard Company Paced QRS complex classifier
US5269301A (en) 1987-10-06 1993-12-14 Leonard Bloom Multimode system for monitoring and treating a malfunctioning heart
US5014698A (en) 1987-10-06 1991-05-14 Leonard Bloom Method of and system for monitoring and treating a malfunctioning heart
US5156148A (en) 1987-10-06 1992-10-20 Leonard Bloom System for treating a malfunctioning heart
US4924875A (en) 1987-10-09 1990-05-15 Biometrak Corporation Cardiac biopotential analysis system and method
US5020540A (en) 1987-10-09 1991-06-04 Biometrak Corporation Cardiac biopotential analysis system and method
US4884345A (en) * 1988-05-12 1989-12-05 Siemens-Pacesetter, Inc. Adjustable template for pacemaker ECG analysis and method of use
US5247021A (en) 1989-06-06 1993-09-21 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Process for preparation of a polymer having reactive terminal group
US5014284A (en) 1989-06-30 1991-05-07 Cardiac Telecom Corporation Discrete slope delta modulation with recovery means
US5000189A (en) 1989-11-15 1991-03-19 Regents Of The University Of Michigan Method and system for monitoring electrocardiographic signals and detecting a pathological cardiac arrhythmia such as ventricular tachycardia
US5086772A (en) 1990-07-30 1992-02-11 Telectronics Pacing Systems, Inc. Arrhythmia control system employing arrhythmia recognition algorithm
US5271411A (en) 1990-09-21 1993-12-21 Colin Electronics Co., Ltd. Method and apparatus for ECG signal analysis and cardiac arrhythmia detection
US5109842A (en) 1990-09-24 1992-05-05 Siemens Pacesetter, Inc. Implantable tachyarrhythmia control system having a patch electrode with an integrated cardiac activity system
US5139028A (en) 1990-10-26 1992-08-18 Telectronics Pacing Systems, Inc. Heart rejection monitoring apparatus and method
US5107850A (en) 1990-11-02 1992-04-28 Cardiac Pacemakers, Inc. Method and apparatus for classifying and treating cardiac arrhythmias based on atrial and ventricular activity
US5193550A (en) 1990-11-30 1993-03-16 Medtronic, Inc. Method and apparatus for discriminating among normal and pathological tachyarrhythmias
US5184615A (en) 1991-03-08 1993-02-09 Telectronics Pacing Systems, Inc. Apparatus and method for detecting abnormal cardiac rhythms using evoked potential measurements in an arrhythmia control system
US5240009A (en) 1991-03-25 1993-08-31 Ventritex, Inc. Medical device with morphology discrimination
AU654552B2 (en) 1991-04-05 1994-11-10 Medtronic, Inc. Subcutaneous multi-electrode sensing system
US5292348A (en) 1991-06-14 1994-03-08 Telectronics Pacing Systems, Inc. Implantable cardioverter/defibrillator and method employing cross-phase spectrum analysis for arrhythmia detection
US5217021A (en) * 1991-07-30 1993-06-08 Telectronics Pacing Systems, Inc. Detection of cardiac arrhythmias using correlation of a cardiac electrical signals and temporal data compression
US5255186A (en) 1991-08-06 1993-10-19 Telectronics Pacing Systems, Inc. Signal averaging of cardiac electrical signals using temporal data compression and scanning correlation
US5215098A (en) 1991-08-12 1993-06-01 Telectronics Pacing Systems, Inc. Data compression of cardiac electrical signals using scanning correlation and temporal data compression
US5478807A (en) 1991-08-19 1995-12-26 Genentech, Inc. Use of relaxin in the treatment of bradycardia
US5280792A (en) 1991-09-20 1994-01-25 The University Of Sydney Method and system for automatically classifying intracardiac electrograms
FR2685643B1 (en) 1991-12-31 1994-03-11 Ela Medical Control Method for an implanted defibrillator.
US5313953A (en) 1992-01-14 1994-05-24 Incontrol, Inc. Implantable cardiac patient monitor
US5312445A (en) 1992-02-03 1994-05-17 Telectronics Pacing Systems, Inc. Implantable cardiac stimulating apparatus and method employing detection of P-waves from signals sensed in the ventricle
EP0560569B1 (en) 1992-03-09 1998-07-15 Angeion Corporation Fibrillation and tachycardia detection
US5330504A (en) 1992-03-16 1994-07-19 Telectronics Pacing Systems, Inc. Cardioverting defibrillating device with off-line ECG analysis
ES2155068T3 (en) 1992-04-03 2001-05-01 Micromedical Ind Ltd Physiological supervision system.
US5360436A (en) 1992-04-03 1994-11-01 Intermedics, Inc. Cardiac pacing responsive to multiple activity types
US5273049A (en) 1992-04-09 1993-12-28 Telectronics Pacing Systems, Inc. Detection of cardiac arrhythmias using template matching by signature analysis
US5275621A (en) 1992-04-13 1994-01-04 Medtronic, Inc. Method and apparatus for terminating tachycardia
US5311874A (en) * 1992-05-18 1994-05-17 Cardiac Pacemakers, Inc. Method for tachycardia discrimination
US5687737A (en) 1992-10-09 1997-11-18 Washington University Computerized three-dimensional cardiac mapping with interactive visual displays
US5342402A (en) 1993-01-29 1994-08-30 Medtronic, Inc. Method and apparatus for detection and treatment of tachycardia and fibrillation
US5421830A (en) 1993-08-27 1995-06-06 Pacesetter, Inc. Programming system having means for recording and analyzing a patient's cardiac signal
US5400795A (en) 1993-10-22 1995-03-28 Telectronics Pacing Systems, Inc. Method of classifying heart rhythms by analyzing several morphology defining metrics derived for a patient's QRS complex
US5411031A (en) 1993-11-24 1995-05-02 Incontrol, Inc. Implantable cardiac patient monitor
US5456261A (en) 1993-12-16 1995-10-10 Marquette Electronics, Inc. Cardiac monitoring and diagnostic system
US5935082A (en) 1995-01-26 1999-08-10 Cambridge Heart, Inc. Assessing cardiac electrical stability
US5713367A (en) 1994-01-26 1998-02-03 Cambridge Heart, Inc. Measuring and assessing cardiac electrical stability
US5458623A (en) 1994-03-04 1995-10-17 Telectronics Pacing Systems, Inc. Automatic atrial pacing threshold determination utilizing an external programmer and a surface electrogram
US5447519A (en) * 1994-03-19 1995-09-05 Medtronic, Inc. Method and apparatus for discrimination of monomorphic and polymorphic arrhythmias and for treatment thereof
US5622178A (en) 1994-05-04 1997-04-22 Spacelabs Medical, Inc. System and method for dynamically displaying cardiac interval data using scatter-plots
US5542430A (en) 1994-09-16 1996-08-06 Telectronics Pacing Systems, Inc. Apparatus and method for discriminating between cardiac rhythms on the basis of their morphology using a neural network
US5520191A (en) 1994-10-07 1996-05-28 Ortivus Medical Ab Myocardial ischemia and infarction analysis and monitoring method and apparatus
IL115603D0 (en) 1994-10-13 1996-01-19 Amgen Inc Method of treating diabetes mellitus using kgf
US5549641A (en) 1994-10-31 1996-08-27 Incontrol, Inc. Atrial fibrillation type selective cardiovertor and method
DE4444144A1 (en) 1994-12-12 1996-06-13 Pacesetter Ab Pacemaker with improved detection of electrical signals
JP3681126B2 (en) 1995-02-17 2005-08-10 ボストン サイエンティフィック リミテッド System for the time-series measurement of biological events
US5797849A (en) 1995-03-28 1998-08-25 Sonometrics Corporation Method for carrying out a medical procedure using a three-dimensional tracking and imaging system
WO1997004702A1 (en) 1995-07-28 1997-02-13 Ep Technologies, Inc. Systems and methods for conducting electrophysiological testing using high-voltage energy pulses to stun heart tissue
US5724985A (en) 1995-08-02 1998-03-10 Pacesetter, Inc. User interface for an implantable medical device using an integrated digitizer display screen
US5848972A (en) 1995-09-15 1998-12-15 Children's Medical Center Corporation Method for endocardial activation mapping using a multi-electrode catheter
US5645070A (en) 1995-09-25 1997-07-08 Ventritex, Inc. Method and apparatus for determining the origins of cardiac arrhythmias morphology dynamics
US5712801A (en) 1995-09-25 1998-01-27 Pacesetter, Inc. Method for characterizing dynamical systems
US5738105A (en) 1995-10-24 1998-04-14 Angeion Corporation Method and apparatus for sensing R-waves using both near field and far field sensing simultaneously
US5682900A (en) * 1995-11-29 1997-11-04 Hewlett-Packard Company Method and apparatus for obtaining heartbeat measurements from a ECG waveform
US5628326A (en) 1995-11-29 1997-05-13 Hewlett-Packard Company Calculating a heart rate from an ECG waveform by discarding a percentage of R-R intervals prior to averaging
US5819007A (en) 1996-03-15 1998-10-06 Siemens Medical Systems, Inc. Feature-based expert system classifier
US5797399A (en) 1996-04-19 1998-08-25 The Regents Of The University Of Michigan Method and apparatus for identifying and correctly responding to abnormal heart activity
US5857977A (en) 1996-08-08 1999-01-12 The Regents Of The University Of Michigan Method and apparatus for separation of ventricular tachycardia from ventricular fibrillation for implantable cardioverter defibrillators
US5778881A (en) 1996-12-04 1998-07-14 Medtronic, Inc. Method and apparatus for discriminating P and R waves
US5755739A (en) 1996-12-04 1998-05-26 Medtronic, Inc. Adaptive and morphological system for discriminating P-waves and R-waves inside the human body
US5779645A (en) 1996-12-17 1998-07-14 Pacesetter, Inc. System and method for waveform morphology comparison
US5817133A (en) 1997-03-04 1998-10-06 Medtronic, Inc. Pacemaker with morphological filtering of sensed cardiac signals
AU730170B2 (en) * 1997-03-12 2001-03-01 University Of Ulster Apparatus for body surface mapping
US5772604A (en) 1997-03-14 1998-06-30 Emory University Method, system and apparatus for determining prognosis in atrial fibrillation
US5792065A (en) 1997-03-18 1998-08-11 Marquette Medical Systems, Inc. Method and apparatus for determining T-wave marker points during QT dispersion analysis
US5954661A (en) 1997-03-31 1999-09-21 Thomas Jefferson University Tissue characterization and treatment using pacing
CA2291039A1 (en) 1997-05-27 1998-12-03 Cardiac Pacemakers, Inc. System and method for ventricular defibrillation
US6096061A (en) 1997-06-12 2000-08-01 Intermedics Inc. Defibrillator with improved hemodynamic response and enhanced myocardial stability
US6076014A (en) 1997-08-01 2000-06-13 Sulzer Intermedics, Inc. Cardiac stimulator and defibrillator with means for identifying cardiac rhythm disorder and chamber of origin
US5827197A (en) * 1997-11-14 1998-10-27 Incontrol, Inc. System for detecting atrial fibrillation notwithstanding high and variable ventricular rates
US6192273B1 (en) * 1997-12-02 2001-02-20 The Cleveland Clinic Foundation Non-programmable automated heart rhythm classifier
US6016442A (en) * 1998-03-25 2000-01-18 Cardiac Pacemakers, Inc. System for displaying cardiac arrhythmia data
US6275732B1 (en) 1998-06-17 2001-08-14 Cardiac Pacemakers, Inc. Multiple stage morphology-based system detecting ventricular tachycardia and supraventricular tachycardia
US6266554B1 (en) * 1999-02-12 2001-07-24 Cardiac Pacemakers, Inc. System and method for classifying cardiac complexes
US6308095B1 (en) 1999-02-12 2001-10-23 Cardiac Pacemakers, Inc. System and method for arrhythmia discrimination
US6312388B1 (en) 1999-03-12 2001-11-06 Cardiac Pacemakers, Inc. Method and system for verifying the integrity of normal sinus rhythm templates
US6223078B1 (en) 1999-03-12 2001-04-24 Cardiac Pacemakers, Inc. Discrimination of supraventricular tachycardia and ventricular tachycardia events
US6285907B1 (en) 1999-05-21 2001-09-04 Cardiac Pacemakers, Inc. System providing ventricular pacing and biventricular coordination
US6351669B1 (en) 1999-05-21 2002-02-26 Cardiac Pacemakers, Inc. Cardiac rhythm management system promoting atrial pacing
US6430438B1 (en) 1999-05-21 2002-08-06 Cardiac Pacemakers, Inc. Cardiac rhythm management system with atrial shock timing optimization
US6314321B1 (en) 1999-06-30 2001-11-06 Cardiac Pacemakers, Inc. Therapy-selection methods for implantable heart monitors
US6449503B1 (en) 1999-07-14 2002-09-10 Cardiac Pacemakers, Inc. Classification of supraventricular and ventricular cardiac rhythms using cross channel timing algorithm
US6434417B1 (en) 2000-03-28 2002-08-13 Cardiac Pacemakers, Inc. Method and system for detecting cardiac depolarization

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6980860B2 (en) 2002-10-31 2005-12-27 Medtronic, Inc. Detection of supraventricular tachycardia with 1:1 atrial to ventricular conduction
US20040088013A1 (en) * 2002-10-31 2004-05-06 Stadler Robert W. Detection of supraventricular tachycardia with 1:1 atrial to ventricular conduction
US7103405B2 (en) 2002-12-04 2006-09-05 Medtronic, Inc. Methods and apparatus for discriminating polymorphic tachyarrhythmias from monomorphic tachyarrhythmias facilitating detection of fibrillation
US20040111121A1 (en) * 2002-12-04 2004-06-10 Brown Mark L. Methods and apparatus for discriminating polymorphic tachyarrhythmias from monomorphic tachyarrhythmias facilitating detection of fibrillation
US20040111120A1 (en) * 2002-12-04 2004-06-10 Shantanu Sarkar Methods and apparatus for discriminating polymorphic tachyarrhythmias from monomorphic tachyarrhythmias facilitating detection of fibrillation
US20040111119A1 (en) * 2002-12-04 2004-06-10 Shantanu Sarkar Methods and apparatus for discriminating polymorphic tachyarrhythmias from monomorphic tachyarrhythmias facilitating detection of fibrillation
US7076289B2 (en) 2002-12-04 2006-07-11 Medtronic, Inc. Methods and apparatus for discriminating polymorphic tachyarrhythmias from monomorphic tachyarrhythmias facilitating detection of fibrillation
US7130677B2 (en) 2002-12-04 2006-10-31 Medtronic, Inc. Methods and apparatus for discriminating polymorphic tachyarrhythmias from monomorphic tachyarrhythmias facilitating detection of fibrillation
US20070016257A1 (en) * 2003-08-29 2007-01-18 Brown Mark L Methods and apparatus for discriminating polymorphic tachyarrhythmias from monomorphic tachyarrhythmias facilitating detection of fibrillation
US8332022B2 (en) 2003-08-29 2012-12-11 Medtronic, Inc. Methods and apparatus for discriminating polymorphic tachyarrhythmias from monomorphic tachyarrhythmias facilitating detection of fibrillation
US7738948B2 (en) 2006-10-31 2010-06-15 Medtronic, Inc. Form parameter forecaster for analyzing signals distorted by noise
US20080103401A1 (en) * 2006-10-31 2008-05-01 Mattias Rouw Form Parameter Forecaster for Analyzing Signals Distorted by Noise
US20080281369A1 (en) * 2007-05-08 2008-11-13 Kenknight Bruce System And Method For Determining The Origin Of A Sensed Beat
US8781581B2 (en) 2007-05-08 2014-07-15 Cardiac Pacemakers, Inc. System and method for determining the origin of a sensed beat
US8442631B2 (en) * 2007-05-08 2013-05-14 Cardiac Pacemakers, Inc. System and method for determining the origin of a sensed beat
US8224443B2 (en) * 2007-05-08 2012-07-17 Cardiac Pacemakers, Inc. Method for controlling pacemaker therapy
US20080281371A1 (en) * 2007-05-08 2008-11-13 Kenknight Bruce Method For Controlling Pacemaker Therapy
WO2011038118A1 (en) * 2009-09-24 2011-03-31 Cardiac Pacemakers, Inc. Morphology based ischemia detection using intracardiac electrograms
US20110071413A1 (en) * 2009-09-24 2011-03-24 Yi Zhang Morphology based ischemia detection using intracardiac electrograms
US20140142443A1 (en) * 2012-11-19 2014-05-22 Pacesetter, Inc. Systems and methods for exploiting pulmonary artery pressure obtained from an implantable sensor to detect cardiac rhythm irregularities
US9301702B2 (en) * 2012-11-19 2016-04-05 Pacesetter, Inc. Systems and methods for exploiting pulmonary artery pressure obtained from an implantable sensor to detect cardiac rhythm irregularities

Also Published As

Publication number Publication date
US6438410B2 (en) 2002-08-20
WO2000047278A9 (en) 2001-10-04
US6266554B1 (en) 2001-07-24
AU3999800A (en) 2000-08-29
US20020193696A1 (en) 2002-12-19
US6728572B2 (en) 2004-04-27
WO2000047278A1 (en) 2000-08-17

Similar Documents

Publication Publication Date Title
US6687540B2 (en) Discrimination of supraventricular tachycardia and ventricular tachycardia events
US7027858B2 (en) Methods and apparatus for cardiac R-wave sensing in a subcutaneous ECG waveform
US7567835B2 (en) Method and apparatus for identifying oversensing using far-field intracardiac electrograms and marker channels
US7818056B2 (en) Blending cardiac rhythm detection processes
EP1339455B1 (en) Automated template generation
AU649177B2 (en) Method and apparatus for discrimination of ventricular tachycardia from ventricular fibrillation and for treatment thereof
US6397100B2 (en) Axis shift analysis of electrocardiogram signal parameters especially applicable for multivector analysis by implantable medical devices, and use of same
JP4625813B2 (en) Classification of cardiac response using a plurality of classification window
US7242978B2 (en) Method and apparatus for generating a template for arrhythmia detection and electrogram morphology classification
US8239020B2 (en) Implantable medical device sensing wireless ECG as substitute for intracardiac electrogram
EP1677673B1 (en) Method and apparatus for detecting and discriminating arrhythmias
US8275456B2 (en) Implantable device for delivering cardiac drug therapy
US8583231B2 (en) Method and system for characterizing supraventricular rhythm during cardiac pacing
EP1601416B1 (en) Detection of tachyarrhythmia termination
EP1569719B1 (en) Systems for discriminating polymorphic from monomorphic tachyarrhythmias
US6381493B1 (en) Ischemia detection during non-standard cardiac excitation patterns
US6108577A (en) Method and apparatus for detecting changes in electrocardiogram signals
US7228173B2 (en) Cardiac tachyarrhythmia therapy selection based on patient response information
US7515956B2 (en) Template based AV/VA interval comparison for the discrimination of cardiac arrhythmias
US4905708A (en) Apparatus for recognizing cardiac rhythms
EP1038498B1 (en) Apparatus for characterising ventricular function
US20120310102A1 (en) Methods and apparatuses for cardiac arrhythmia classification using dynamic beatdriven morphological feature extraction
US7933651B2 (en) Cardiac template generation based on patient response information
US7130681B2 (en) Use of accelerometer signal to augment ventricular arrhythmia detection
US6516225B1 (en) System and method for distinguishing electrical events originating in the atria from far-field electrical events originating in the ventricles as detected by an implantable medical device

Legal Events

Date Code Title Description
FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Expired due to failure to pay maintenance fee

Effective date: 20140820